AlphBeta的个人主页 - 老虎社区

AlphBeta

暂无个人介绍

IP属地：未知

1关注

11粉丝

0主题

0勋章

2021-08-12

👍

抱歉，原内容已删除

2021-12-15

👍

Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation<blockquote>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</blockquote>

2021-09-29

👍

These high-flying stocks of 2021 dropped the most on Tuesday<blockquote>这些2021年飞涨的股票周二跌幅最大</blockquote>

2021-08-31

👍

抱歉，原内容已删除

2021-08-22

👍

Ignore Elon Musk’s dancing distraction and face the dangers ahead for Tesla<blockquote>忽略Elon Musk跳舞的干扰，面对特斯拉未来的危险</blockquote>

2021-08-06

👍

Airline shares, Carnival stocks rally in morning trading<blockquote>航空股、嘉年华股早盘上涨</blockquote>

2021-11-26

👍

抱歉，原内容已删除

2021-11-12

👍

Is AFRM A Buy Now? What Affirm's Fundamentals, IBD Ratings, Stock Chart Say<blockquote>AFRM现在值得买入吗？Affirm的基本面、IBD评级、股票图表说明了什么</blockquote>

2021-11-01

👍

XPeng shares jumped 2.5% in premarket trading<blockquote>小鹏汽车股价在盘前交易中上涨2.5%</blockquote>

2021-08-08

👍

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3560475301779740","uuid":"3560475301779740","gmtCreate":1597994247458,"gmtModify":1597994247458,"name":"AlphBeta","pinyin":"alphbeta","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":11,"headSize":1,"tweetSize":156,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":607276932,"gmtCreate":1639553942521,"gmtModify":1639553942651,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607276932","repostId":"1107549050","repostType":4,"repost":{"id":"1107549050","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639552499,"share":"https://www.laohu8.com/m/news/1107549050?lang=zh_CN&edition=full","pubTime":"2021-12-15 15:14","market":"us","language":"en","title":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation<blockquote>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107549050","media":"Tiger Newspress","summary":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and c","content":"<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p><p><blockquote><b>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</b></blockquote></p><p> <ul>  <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>  <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>  <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li> </ul> Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p><p><blockquote><ul><li>阳性加强剂数据显示，接受的所有初级疫苗（mRNA或腺病毒）中的中和抗体增加了9至43倍，并且对于所有测试的年龄组，具有良好的安全性和耐受性</li><li>随着世界各地的人群越来越多地暴露于新冠肺炎变种，3期试验继续增加分析所需的事件数量；预计2022年第一季度业绩</li><li>公司打算在第三阶段结果公布后向监管机构提交加强数据</li></ul>赛诺菲和葛兰素史克今天宣布，他们的重组佐剂新冠肺炎候选疫苗的单次加强剂量产生了持续强烈的免疫反应。调查加强剂安全性和免疫原性的VAT0002临床试验的初步结果显示，无论接受的初级疫苗（阿斯利康、强生、Moderna、辉瑞/BioNTech）和所有测试年龄组，中和抗体都增加了9至43倍。加强剂耐受性良好，安全性与目前批准的新冠肺炎疫苗相似。这是迄今为止最全面的加强试验，旨在探索用于初级疫苗接种的不同疫苗技术的加强。</blockquote></p><p> The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p><p><blockquote>正在进行的全球3期试验VAT0008包括独立数据安全监测委员会(DSMB)的定期审查。在上次审查中，DSMB没有发现任何安全问题，并建议试验继续到2022年初，以积累更多数据。</blockquote></p><p> Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p><p><blockquote>监管机构要求在“幼稚”人群中证明3期疗效，即从未感染过新冠肺炎病毒（血清阴性）的参与者。3期试验在2021年第三季度招募了大多数参与者，恰逢德尔塔变异毒株导致全球感染COVID-19病毒的人数大幅增加。为了向监管机构提供加强疫苗提交所需的数据，该试验将继续累积分析所需的事件数量，预计将于2022年第一季度得出结果。</blockquote></p><p> <i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p><p><blockquote><i>“这些初步数据表明，无论您接种的是什么初级疫苗，我们都有一种强大的加强候选疫苗。”</i>赛诺菲巴斯德执行副总裁Thomas Triomphe说道。<i>“这与我们为不断变化的公共卫生需求提供相关响应的努力是一致的。虽然在快速变化的大流行环境中进行3期试验是一项挑战，但我们期待看到结果，以支持尽快提交我们的加强疫苗。”</i></blockquote></p><p> Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p><p><blockquote>葛兰素史克疫苗总裁罗杰·康纳补充道<i>：“随着大流行威胁的持续，目前占主导地位的德尔塔变异毒株和奥密克戎迅速取得进展，随着时间的推移，将继续需要加强疫苗来帮助保护人们。最初的加强数据很有希望，我们正在等待III期结果，以确定提供基于蛋白质的佐剂COVID-19疫苗的下一步措施。”</i></blockquote></p><p> In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p><p><blockquote>与此同时，赛诺菲继续为全球公共卫生需求做出贡献，生产了多达5亿剂BioNTech/辉瑞、Moderna和强生疫苗。</blockquote></p><p> <b>About the booster trial (VAT0002)</b></p><p><blockquote><b>关于加强试验（VAT0002）</b></blockquote></p><p> The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p><p><blockquote>VAT0002扩展试验是迄今为止进行的最全面的异源加强试验。在该试验的第一个队列中，使用mRNA和腺病毒载体技术的四种最广泛批准的新冠肺炎初级疫苗在完全初级疫苗接种后用赛诺菲/GSK基于蛋白质的佐剂候选疫苗加强，以评估其安全性和免疫原性。</blockquote></p><p> Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p><p><blockquote>第一个队列（n=521）的参与者之前已经接种了授权的新冠肺炎mRNA疫苗（Moderna，辉瑞/BioNTech）或腺病毒载体疫苗（阿斯利康，强生）的批准给药方案。该初步分析包括试验参与者的数据，这些参与者在完成初级疫苗接种计划后4至10个月期间接受了一次5µg加强剂量的针对D614亲本病毒的佐剂重组蛋白疫苗。</blockquote></p><p> The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p><p><blockquote>该试验正在多个国家进行，包括美国、法国和英国。为了解决令人担忧的新冠肺炎变异体的出现，其他试验队列正在评估也含有β（B.1.351）变异体的单价和二价疫苗制剂的加强潜力。该试验的更多数据预计将在2022年上半年公布。奥密克戎变种在试验期间没有传播。使用加强试验参与者的血清，正在进行测试，以确定候选疫苗交叉中和奥密克戎病毒的能力。</blockquote></p><p> <b>About the Phase 3 efficacy trial (VAT0008)</b></p><p><blockquote><b>关于3期疗效试验（VAT0008）</b></blockquote></p><p></p><p> The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p><p><blockquote>这项正在进行的3期、随机、双盲、安慰剂对照试验的主要终点是在新型冠状病毒初治成人中预防有症状的COVID-19，次要终点是预防严重的COVID-19疾病和感染。该试验的第一阶段正在评估含有刺突蛋白的疫苗制剂对原始D614（亲代）病毒的功效，超过10,000名年龄&gt;18岁的参与者随机接受两剂10µg疫苗或安慰剂在美国、亚洲、非洲和拉丁美洲的研究中心第1天和第22天。试验的第二阶段是评估第二种二价制剂，添加B.1.351（β）变体的刺突蛋白。</blockquote></p><p> These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p><p><blockquote>这些努力得到了生物医学高级研究与发展局的联邦资金的支持，该局是美国负责准备和响应的助理部长办公室的一部分。卫生与公众服务部与美国合作。国防部化学、生物、辐射和核防御联合计划执行办公室，合同号为W15QKN-16-9-1002。</blockquote></p><p> <b>About the Sanofi and GSK collaboration</b></p><p><blockquote><b>关于赛诺菲与葛兰素史克合作</b></blockquote></p><p> In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p><p><blockquote>在两家公司的合作中，赛诺菲提供其重组抗原，葛兰素史克提供其大流行佐剂，这两个已建立的疫苗平台已被证明在对抗流感方面是成功的。</blockquote></p><p> <b>About GSK</b></p><p><blockquote><b>关于GSK</b></blockquote></p><p> GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p><p><blockquote>葛兰素史克是一家以科学为主导的全球医疗保健公司，有着特殊的目标：帮助人们做得更多，感觉更好，活得更长。葛兰素史克是全球领先的疫苗制造商。</blockquote></p><p> <b>About Sanofi</b></p><p><blockquote><b>关于赛诺菲</b></blockquote></p><p> Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p><p><blockquote>赛诺菲致力于支持人们应对健康挑战。是一家专注于人类健康的全球性生物制药公司。它通过疫苗预防疾病，提供创新的治疗方法来对抗疼痛和减轻痛苦。它支持少数患有罕见疾病的人和数百万患有长期慢性病的人。</blockquote></p><p> With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p><p><blockquote>赛诺菲在100个国家拥有超过100,000名员工，正在将科学创新转化为全球医疗保健解决方案。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation<blockquote>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation<blockquote>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-15 15:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p><p><blockquote><b>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</b></blockquote></p><p> <ul>  <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>  <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>  <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li> </ul> Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p><p><blockquote><ul><li>阳性加强剂数据显示，接受的所有初级疫苗（mRNA或腺病毒）中的中和抗体增加了9至43倍，并且对于所有测试的年龄组，具有良好的安全性和耐受性</li><li>随着世界各地的人群越来越多地暴露于新冠肺炎变种，3期试验继续增加分析所需的事件数量；预计2022年第一季度业绩</li><li>公司打算在第三阶段结果公布后向监管机构提交加强数据</li></ul>赛诺菲和葛兰素史克今天宣布，他们的重组佐剂新冠肺炎候选疫苗的单次加强剂量产生了持续强烈的免疫反应。调查加强剂安全性和免疫原性的VAT0002临床试验的初步结果显示，无论接受的初级疫苗（阿斯利康、强生、Moderna、辉瑞/BioNTech）和所有测试年龄组，中和抗体都增加了9至43倍。加强剂耐受性良好，安全性与目前批准的新冠肺炎疫苗相似。这是迄今为止最全面的加强试验，旨在探索用于初级疫苗接种的不同疫苗技术的加强。</blockquote></p><p> The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p><p><blockquote>正在进行的全球3期试验VAT0008包括独立数据安全监测委员会(DSMB)的定期审查。在上次审查中，DSMB没有发现任何安全问题，并建议试验继续到2022年初，以积累更多数据。</blockquote></p><p> Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p><p><blockquote>监管机构要求在“幼稚”人群中证明3期疗效，即从未感染过新冠肺炎病毒（血清阴性）的参与者。3期试验在2021年第三季度招募了大多数参与者，恰逢德尔塔变异毒株导致全球感染COVID-19病毒的人数大幅增加。为了向监管机构提供加强疫苗提交所需的数据，该试验将继续累积分析所需的事件数量，预计将于2022年第一季度得出结果。</blockquote></p><p> <i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p><p><blockquote><i>“这些初步数据表明，无论您接种的是什么初级疫苗，我们都有一种强大的加强候选疫苗。”</i>赛诺菲巴斯德执行副总裁Thomas Triomphe说道。<i>“这与我们为不断变化的公共卫生需求提供相关响应的努力是一致的。虽然在快速变化的大流行环境中进行3期试验是一项挑战，但我们期待看到结果，以支持尽快提交我们的加强疫苗。”</i></blockquote></p><p> Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p><p><blockquote>葛兰素史克疫苗总裁罗杰·康纳补充道<i>：“随着大流行威胁的持续，目前占主导地位的德尔塔变异毒株和奥密克戎迅速取得进展，随着时间的推移，将继续需要加强疫苗来帮助保护人们。最初的加强数据很有希望，我们正在等待III期结果，以确定提供基于蛋白质的佐剂COVID-19疫苗的下一步措施。”</i></blockquote></p><p> In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p><p><blockquote>与此同时，赛诺菲继续为全球公共卫生需求做出贡献，生产了多达5亿剂BioNTech/辉瑞、Moderna和强生疫苗。</blockquote></p><p> <b>About the booster trial (VAT0002)</b></p><p><blockquote><b>关于加强试验（VAT0002）</b></blockquote></p><p> The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p><p><blockquote>VAT0002扩展试验是迄今为止进行的最全面的异源加强试验。在该试验的第一个队列中，使用mRNA和腺病毒载体技术的四种最广泛批准的新冠肺炎初级疫苗在完全初级疫苗接种后用赛诺菲/GSK基于蛋白质的佐剂候选疫苗加强，以评估其安全性和免疫原性。</blockquote></p><p> Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p><p><blockquote>第一个队列（n=521）的参与者之前已经接种了授权的新冠肺炎mRNA疫苗（Moderna，辉瑞/BioNTech）或腺病毒载体疫苗（阿斯利康，强生）的批准给药方案。该初步分析包括试验参与者的数据，这些参与者在完成初级疫苗接种计划后4至10个月期间接受了一次5µg加强剂量的针对D614亲本病毒的佐剂重组蛋白疫苗。</blockquote></p><p> The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p><p><blockquote>该试验正在多个国家进行，包括美国、法国和英国。为了解决令人担忧的新冠肺炎变异体的出现，其他试验队列正在评估也含有β（B.1.351）变异体的单价和二价疫苗制剂的加强潜力。该试验的更多数据预计将在2022年上半年公布。奥密克戎变种在试验期间没有传播。使用加强试验参与者的血清，正在进行测试，以确定候选疫苗交叉中和奥密克戎病毒的能力。</blockquote></p><p> <b>About the Phase 3 efficacy trial (VAT0008)</b></p><p><blockquote><b>关于3期疗效试验（VAT0008）</b></blockquote></p><p></p><p> The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p><p><blockquote>这项正在进行的3期、随机、双盲、安慰剂对照试验的主要终点是在新型冠状病毒初治成人中预防有症状的COVID-19，次要终点是预防严重的COVID-19疾病和感染。该试验的第一阶段正在评估含有刺突蛋白的疫苗制剂对原始D614（亲代）病毒的功效，超过10,000名年龄&gt;18岁的参与者随机接受两剂10µg疫苗或安慰剂在美国、亚洲、非洲和拉丁美洲的研究中心第1天和第22天。试验的第二阶段是评估第二种二价制剂，添加B.1.351（β）变体的刺突蛋白。</blockquote></p><p> These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p><p><blockquote>这些努力得到了生物医学高级研究与发展局的联邦资金的支持，该局是美国负责准备和响应的助理部长办公室的一部分。卫生与公众服务部与美国合作。国防部化学、生物、辐射和核防御联合计划执行办公室，合同号为W15QKN-16-9-1002。</blockquote></p><p> <b>About the Sanofi and GSK collaboration</b></p><p><blockquote><b>关于赛诺菲与葛兰素史克合作</b></blockquote></p><p> In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p><p><blockquote>在两家公司的合作中，赛诺菲提供其重组抗原，葛兰素史克提供其大流行佐剂，这两个已建立的疫苗平台已被证明在对抗流感方面是成功的。</blockquote></p><p> <b>About GSK</b></p><p><blockquote><b>关于GSK</b></blockquote></p><p> GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p><p><blockquote>葛兰素史克是一家以科学为主导的全球医疗保健公司，有着特殊的目标：帮助人们做得更多，感觉更好，活得更长。葛兰素史克是全球领先的疫苗制造商。</blockquote></p><p> <b>About Sanofi</b></p><p><blockquote><b>关于赛诺菲</b></blockquote></p><p> Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p><p><blockquote>赛诺菲致力于支持人们应对健康挑战。是一家专注于人类健康的全球性生物制药公司。它通过疫苗预防疾病，提供创新的治疗方法来对抗疼痛和减轻痛苦。它支持少数患有罕见疾病的人和数百万患有长期慢性病的人。</blockquote></p><p> With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p><p><blockquote>赛诺菲在100个国家拥有超过100,000名员工，正在将科学创新转化为全球医疗保健解决方案。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克","SNY":"赛诺菲安万特"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107549050","content_text":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation\n\nPositive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile\nPhase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022\nCompanies intend to file booster data with regulatory authorities following the Phase 3 results\n\nSanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.\nThe ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.\nRegulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.\n“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”\nRoger Connor, President of GSK Vaccines, added: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"\nIn parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson & Johnson vaccines.\nAbout the booster trial (VAT0002)\nThe VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.\nParticipants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson & Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.\nThe trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.\nAbout the Phase 3 efficacy trial (VAT0008)\nThe primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants >18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.\nThese efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.\nAbout the Sanofi and GSK collaboration\nIn the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.\nAbout GSK\nGSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.\nAbout Sanofi\nSanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.\nWith more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.","news_type":1,"symbols_score_info":{"SNY":0.9,"GSK":0.9}},"isVote":1,"tweetType":1,"viewCount":2387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604404875,"gmtCreate":1639435682260,"gmtModify":1639435929630,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604404875","repostId":"2191984549","repostType":4,"isVote":1,"tweetType":1,"viewCount":2583,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604289833,"gmtCreate":1639402537839,"gmtModify":1639402538337,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604289833","repostId":"1161576842","repostType":4,"repost":{"id":"1161576842","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639400492,"share":"https://www.laohu8.com/m/news/1161576842?lang=zh_CN&edition=full","pubTime":"2021-12-13 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1161576842","media":"Tiger Newspress","summary":"U.S. stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-ba","content":"<p>U.S.&nbsp;stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p><p><blockquote>美国股指期货显示，在主要经济体央行决策繁忙的一周之前，主要股指涨幅温和。</blockquote></p><p> At 8:00 a.m. ET, S&amp;P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.<img src=\"https://static.tigerbbs.com/2db870f3d308c4d0618dd8c4333e65dd\" tg-width=\"1080\" tg-height=\"383\" referrerpolicy=\"no-referrer\">The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.</p><p><blockquote>截至美国东部时间上午8:00，标普500 e-minis上涨11.25点，涨幅0.24%，纳斯达克100 e-minis上涨67点，涨幅0.41%，道指e-minis上涨24点，涨幅0.07%。关键的通胀数据是在美联储本周举行为期两天的政策会议之前发布的，预计政策制定者将在会上讨论加快结束债券购买计划。</blockquote></p><p> Fed Chair Jerome Powell, as well as&nbsp;a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.</p><p><blockquote>美联储主席杰罗姆·鲍威尔以及一系列美联储发言人最近都表示，美联储可能会比目前的2022年6月时间表更早结束每月1200亿美元的债券购买计划。</blockquote></p><p> “We believe markets can continue to&nbsp;take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.</p><p><blockquote>马克·海菲尔表示：“我们相信，尽管额外的波动仍然是一个风险，但市场可以继续从容应对更高的通胀数据。由于美联储政策保持相对宽松，股市的背景仍然是积极的，我们看好全球增长的赢家。”瑞银全球财富管理首席投资官。</blockquote></p><p> As of Sunday, the&nbsp;U.S. was approaching&nbsp;800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.</p><p><blockquote>截至周日，美国。与冠状病毒相关的死亡人数接近80万。这种新变种促使一些政府官员恢复健康限制以减缓传播。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b><a href=\"https://laohu8.com/S/HOG\">Harley-Davidson</a></b>– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”</p><p><blockquote><b><a href=\"https://laohu8.com/S/HOG\">哈雷-戴维森</a></b>–这家摩托车制造商宣布将其“Livewire”电动摩托车部门与一家特殊目的收购公司合并后，其股价在盘前飙升11.7%。Livewire的企业价值约为18亿美元，将在纽约证券交易所交易，股票代码为“LVW”。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </b>– <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> rose 1.4% in the premarket while <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> jumped 4.4% after&nbsp;a new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.</p><p><blockquote><b><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>–<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>盘前上涨1.4%<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>以色列的一项新研究表明，他们的新冠肺炎疫苗加强注射可以为预防奥密克戎变种引起的严重疾病提供强有力的保护，这一数字跃升了4.4%。<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>在收购Arena Pharmaceuticals的消息传出后，该公司的盘前涨幅被削减。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals</a> </b>– The drugmaker&nbsp;agreed to be acquired by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&nbsp;for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a></b>-制药商同意被收购<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>每股现金100美元，约合67亿美元。交易消息传出后，Arena在盘前交易中飙升93.1%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/PTON\">Peloton Interactive, Inc.</a></b> – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad&nbsp;featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.</p><p><blockquote><b><a href=\"https://laohu8.com/S/PTON\">佩洛顿互动公司。</a></b>-这家健身器材制造商在过去三个交易日下跌7%后，在盘前反弹2.6%。Peloton发布了一则由演员克里斯·诺斯(Chris Noth)主演的广告，宣传该公司设备的价值，此前他的角色在《欲望都市》重启中乘坐Peloton后去世。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> </b>– The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.</p><p><blockquote><b><a href=\"https://laohu8.com/S/DLTR\">美元树</a></b>–在激进投资者Mantle Ridge宣布打算尝试更换整个Dollar Tree董事会后，这家折扣零售商的股价在盘前交易中下跌1%。Dollar Tree称此举“毫无根据的咄咄逼人”，并表示已提出与拥有Dollar Tree 5.7%股份的Mantle Ridge寻求和解。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/AAPL\">Apple</a> </b>– <a href=\"https://laohu8.com/S/AAPL\">Apple</a> rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.</p><p><blockquote><b><a href=\"https://laohu8.com/S/AAPL\">苹果</a></b>–<a href=\"https://laohu8.com/S/AAPL\">苹果</a>摩根大通证券将该股目标价从每股180美元上调至每股210美元的华尔街高点，并重申其是2022年的首选，该股盘前上涨1.1%。</blockquote></p><p> Nasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include&nbsp;<b><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></b>, up 2.7%;<b><a href=\"https://laohu8.com/S/ABNB\">Airbnb, Inc.</a></b> , up 2.1%;<b><a href=\"https://laohu8.com/S/FTNT\">Fortinet</a></b> , up 3.7%;<b><a href=\"https://laohu8.com/S/LCID\">Lucid Group Inc</a></b>, up 5.9%;<b><a href=\"https://laohu8.com/S/ZS\">Zscaler Inc.</a></b>, up 3.4%; and&nbsp;<b><a href=\"https://laohu8.com/S/DDOG\">Datadog</a></b>, up 3.1%.</p><p><blockquote>纳斯达克100指数成分股——截至12月20日星期一，被纳入该指数的股票在纳入该指数的消息传出后，在盘前交易中上涨。股票包括<b><a href=\"https://laohu8.com/S/PANW\">帕洛阿尔托网络</a></b>，上涨2.7%；<b><a href=\"https://laohu8.com/S/ABNB\">爱彼迎公司。</a></b>，上涨2.1%；<b><a href=\"https://laohu8.com/S/FTNT\">Fortinet</a></b>，上涨3.7%；<b><a href=\"https://laohu8.com/S/LCID\">Lucid集团公司</a></b>，上涨5.9%；<b><a href=\"https://laohu8.com/S/ZS\">Zscaler公司。</a></b>，上涨3.4%；和<b><a href=\"https://laohu8.com/S/DDOG\">Datadog</a></b>，上涨3.1%。</blockquote></p><p> Nasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include&nbsp;<b><a href=\"https://laohu8.com/S/CDW\">CDW Corp</a></b> , down 1.8% in the premarket;<b><a href=\"https://laohu8.com/S/FOXA\">Fox Corporation Class A</a></b> , down 2.2%;<b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> , down 1.8%;<b><a href=\"https://laohu8.com/S/CHKP\">Check Point</a></b> , down 1.1%;<b><a href=\"https://laohu8.com/S/TCOM\">Trip.com Group Limited</a></b> , down 1.2%; and&nbsp;<b><a href=\"https://laohu8.com/S/INCY\">Incyte</a></b>, down 0.6%.</p><p><blockquote>纳斯达克100指数减法-纳斯达克100指数中被替换的股票包括<b><a href=\"https://laohu8.com/S/CDW\">CDW公司</a></b>，盘前跌1.8%；<b><a href=\"https://laohu8.com/S/FOXA\">福克斯公司A级</a></b>，下跌2.2%；<b><a href=\"https://laohu8.com/S/CERN\">塞尔纳</a></b>，下跌1.8%；<b><a href=\"https://laohu8.com/S/CHKP\">检查点</a></b>，下跌1.1%；<b><a href=\"https://laohu8.com/S/TCOM\">携程集团有限公司</a></b>，下跌1.2%；和<b><a href=\"https://laohu8.com/S/INCY\">Incyte</a></b>，下跌0.6%。</blockquote></p><p></p><p> <b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named&nbsp;Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.</p><p><blockquote><b><a href=\"https://laohu8.com/S/RIVN\">Rivian汽车公司。</a></b>–有消息称其R1T击败福特、通用汽车和现代，被《Motor Trend》评为年度卡车，该电动汽车制造商的股价在盘前上涨1.9%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday<blockquote>周一美国市场开盘前的顶线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-13 21:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S.&nbsp;stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p><p><blockquote>美国股指期货显示，在主要经济体央行决策繁忙的一周之前，主要股指涨幅温和。</blockquote></p><p> At 8:00 a.m. ET, S&amp;P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.<img src=\"https://static.tigerbbs.com/2db870f3d308c4d0618dd8c4333e65dd\" tg-width=\"1080\" tg-height=\"383\" referrerpolicy=\"no-referrer\">The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.</p><p><blockquote>截至美国东部时间上午8:00，标普500 e-minis上涨11.25点，涨幅0.24%，纳斯达克100 e-minis上涨67点，涨幅0.41%，道指e-minis上涨24点，涨幅0.07%。关键的通胀数据是在美联储本周举行为期两天的政策会议之前发布的，预计政策制定者将在会上讨论加快结束债券购买计划。</blockquote></p><p> Fed Chair Jerome Powell, as well as&nbsp;a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.</p><p><blockquote>美联储主席杰罗姆·鲍威尔以及一系列美联储发言人最近都表示，美联储可能会比目前的2022年6月时间表更早结束每月1200亿美元的债券购买计划。</blockquote></p><p> “We believe markets can continue to&nbsp;take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.</p><p><blockquote>马克·海菲尔表示：“我们相信，尽管额外的波动仍然是一个风险，但市场可以继续从容应对更高的通胀数据。由于美联储政策保持相对宽松，股市的背景仍然是积极的，我们看好全球增长的赢家。”瑞银全球财富管理首席投资官。</blockquote></p><p> As of Sunday, the&nbsp;U.S. was approaching&nbsp;800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.</p><p><blockquote>截至周日，美国。与冠状病毒相关的死亡人数接近80万。这种新变种促使一些政府官员恢复健康限制以减缓传播。</blockquote></p><p> <b>Stocks making the biggest moves premarket: </b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <b><a href=\"https://laohu8.com/S/HOG\">Harley-Davidson</a></b>– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”</p><p><blockquote><b><a href=\"https://laohu8.com/S/HOG\">哈雷-戴维森</a></b>–这家摩托车制造商宣布将其“Livewire”电动摩托车部门与一家特殊目的收购公司合并后，其股价在盘前飙升11.7%。Livewire的企业价值约为18亿美元，将在纽约证券交易所交易，股票代码为“LVW”。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </b>– <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> rose 1.4% in the premarket while <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> jumped 4.4% after&nbsp;a new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.</p><p><blockquote><b><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>–<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>盘前上涨1.4%<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>以色列的一项新研究表明，他们的新冠肺炎疫苗加强注射可以为预防奥密克戎变种引起的严重疾病提供强有力的保护，这一数字跃升了4.4%。<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>在收购Arena Pharmaceuticals的消息传出后，该公司的盘前涨幅被削减。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals</a> </b>– The drugmaker&nbsp;agreed to be acquired by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&nbsp;for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.</p><p><blockquote><b><a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a></b>-制药商同意被收购<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>每股现金100美元，约合67亿美元。交易消息传出后，Arena在盘前交易中飙升93.1%。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/PTON\">Peloton Interactive, Inc.</a></b> – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad&nbsp;featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.</p><p><blockquote><b><a href=\"https://laohu8.com/S/PTON\">佩洛顿互动公司。</a></b>-这家健身器材制造商在过去三个交易日下跌7%后，在盘前反弹2.6%。Peloton发布了一则由演员克里斯·诺斯(Chris Noth)主演的广告，宣传该公司设备的价值，此前他的角色在《欲望都市》重启中乘坐Peloton后去世。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> </b>– The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.</p><p><blockquote><b><a href=\"https://laohu8.com/S/DLTR\">美元树</a></b>–在激进投资者Mantle Ridge宣布打算尝试更换整个Dollar Tree董事会后，这家折扣零售商的股价在盘前交易中下跌1%。Dollar Tree称此举“毫无根据的咄咄逼人”，并表示已提出与拥有Dollar Tree 5.7%股份的Mantle Ridge寻求和解。</blockquote></p><p> <b><a href=\"https://laohu8.com/S/AAPL\">Apple</a> </b>– <a href=\"https://laohu8.com/S/AAPL\">Apple</a> rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.</p><p><blockquote><b><a href=\"https://laohu8.com/S/AAPL\">苹果</a></b>–<a href=\"https://laohu8.com/S/AAPL\">苹果</a>摩根大通证券将该股目标价从每股180美元上调至每股210美元的华尔街高点，并重申其是2022年的首选，该股盘前上涨1.1%。</blockquote></p><p> Nasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include&nbsp;<b><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></b>, up 2.7%;<b><a href=\"https://laohu8.com/S/ABNB\">Airbnb, Inc.</a></b> , up 2.1%;<b><a href=\"https://laohu8.com/S/FTNT\">Fortinet</a></b> , up 3.7%;<b><a href=\"https://laohu8.com/S/LCID\">Lucid Group Inc</a></b>, up 5.9%;<b><a href=\"https://laohu8.com/S/ZS\">Zscaler Inc.</a></b>, up 3.4%; and&nbsp;<b><a href=\"https://laohu8.com/S/DDOG\">Datadog</a></b>, up 3.1%.</p><p><blockquote>纳斯达克100指数成分股——截至12月20日星期一，被纳入该指数的股票在纳入该指数的消息传出后，在盘前交易中上涨。股票包括<b><a href=\"https://laohu8.com/S/PANW\">帕洛阿尔托网络</a></b>，上涨2.7%；<b><a href=\"https://laohu8.com/S/ABNB\">爱彼迎公司。</a></b>，上涨2.1%；<b><a href=\"https://laohu8.com/S/FTNT\">Fortinet</a></b>，上涨3.7%；<b><a href=\"https://laohu8.com/S/LCID\">Lucid集团公司</a></b>，上涨5.9%；<b><a href=\"https://laohu8.com/S/ZS\">Zscaler公司。</a></b>，上涨3.4%；和<b><a href=\"https://laohu8.com/S/DDOG\">Datadog</a></b>，上涨3.1%。</blockquote></p><p> Nasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include&nbsp;<b><a href=\"https://laohu8.com/S/CDW\">CDW Corp</a></b> , down 1.8% in the premarket;<b><a href=\"https://laohu8.com/S/FOXA\">Fox Corporation Class A</a></b> , down 2.2%;<b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> , down 1.8%;<b><a href=\"https://laohu8.com/S/CHKP\">Check Point</a></b> , down 1.1%;<b><a href=\"https://laohu8.com/S/TCOM\">Trip.com Group Limited</a></b> , down 1.2%; and&nbsp;<b><a href=\"https://laohu8.com/S/INCY\">Incyte</a></b>, down 0.6%.</p><p><blockquote>纳斯达克100指数减法-纳斯达克100指数中被替换的股票包括<b><a href=\"https://laohu8.com/S/CDW\">CDW公司</a></b>，盘前跌1.8%；<b><a href=\"https://laohu8.com/S/FOXA\">福克斯公司A级</a></b>，下跌2.2%；<b><a href=\"https://laohu8.com/S/CERN\">塞尔纳</a></b>，下跌1.8%；<b><a href=\"https://laohu8.com/S/CHKP\">检查点</a></b>，下跌1.1%；<b><a href=\"https://laohu8.com/S/TCOM\">携程集团有限公司</a></b>，下跌1.2%；和<b><a href=\"https://laohu8.com/S/INCY\">Incyte</a></b>，下跌0.6%。</blockquote></p><p></p><p> <b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named&nbsp;Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.</p><p><blockquote><b><a href=\"https://laohu8.com/S/RIVN\">Rivian汽车公司。</a></b>–有消息称其R1T击败福特、通用汽车和现代，被《Motor Trend》评为年度卡车，该电动汽车制造商的股价在盘前上涨1.9%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CERN":"美国塞纳","CHKP":"Check Point软件科技","HOG":"哈雷戴维森",".IXIC":"NASDAQ Composite","LCID":"Lucid Group Inc","ARNA":"阿里那","FTNT":"飞塔信息","TCOM":"携程网","INCY":"因塞特医疗",".DJI":"道琼斯","DDOG":"Datadog","CDW":"CDW Corporation","PANW":"Palo Alto Networks","ZS":"Zscaler Inc.","AAPL":"苹果","RIVN":"Rivian Automotive, Inc.","ABNB":"爱彼迎","PTON":"Peloton Interactive, Inc.","FOXA":"福克斯-A","BNTX":"BioNTech SE","PFE":"辉瑞",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161576842","content_text":"U.S. stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.\nAt 8:00 a.m. ET, S&P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.\nFed Chair Jerome Powell, as well as a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.\n“We believe markets can continue to take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.\nAs of Sunday, the U.S. was approaching 800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.\nStocks making the biggest moves premarket: \nHarley-Davidson– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”\nPfizer,BioNTech SE – Pfizer rose 1.4% in the premarket while BioNTech SE jumped 4.4% after a new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. Pfizer’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.\nArena Pharmaceuticals – The drugmaker agreed to be acquired by Pfizer for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.\nPeloton Interactive, Inc. – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.\nDollar Tree – The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.\nApple – Apple rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.\nNasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include Palo Alto Networks, up 2.7%;Airbnb, Inc. , up 2.1%;Fortinet , up 3.7%;Lucid Group Inc, up 5.9%;Zscaler Inc., up 3.4%; and Datadog, up 3.1%.\nNasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include CDW Corp , down 1.8% in the premarket;Fox Corporation Class A , down 2.2%;Cerner , down 1.8%;Check Point , down 1.1%;Trip.com Group Limited , down 1.2%; and Incyte, down 0.6%.\nRivian Automotive, Inc. – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.","news_type":1,"symbols_score_info":{"ARNA":0.9,".SPX":0.9,"HOG":0.9,"CDW":0.9,"PFE":0.9,"ZS":0.9,"CHKP":0.9,"PTON":0.9,"PANW":0.9,"TCOM":0.9,"CERN":0.9,".DJI":0.9,"DDOG":0.9,"ABNB":0.9,"FOXA":0.9,"LCID":0.9,"AAPL":0.9,"BNTX":0.9,"INCY":0.9,"FTNT":0.9,".IXIC":0.9,"RIVN":0.9}},"isVote":1,"tweetType":1,"viewCount":2378,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604948585,"gmtCreate":1639320869718,"gmtModify":1639320869881,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604948585","repostId":"2190719916","repostType":4,"isVote":1,"tweetType":1,"viewCount":2148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605675357,"gmtCreate":1639173757877,"gmtModify":1639173758009,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605675357","repostId":"1133027099","repostType":4,"repost":{"id":"1133027099","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639152670,"share":"https://www.laohu8.com/m/news/1133027099?lang=zh_CN&edition=full","pubTime":"2021-12-11 00:11","market":"us","language":"en","title":"Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133027099","media":"Tiger Newspress","summary":"Sea Ltd stock dropped more than 5% in morning trading.","content":"<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSea Ltd stock dropped more than 5% in morning trading<blockquote>Sea Ltd股价早盘下跌超过5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-11 00:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sea Ltd stock dropped more than 5% in morning trading.</p><p><blockquote>Sea Ltd股价早盘下跌超过5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f6295277426435ac2c7135ba73dfbdef\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133027099","content_text":"Sea Ltd stock dropped more than 5% in morning trading.","news_type":1,"symbols_score_info":{"SE":0.9}},"isVote":1,"tweetType":1,"viewCount":3644,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605382267,"gmtCreate":1639114611567,"gmtModify":1639114611699,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605382267","repostId":"1185791394","repostType":4,"repost":{"id":"1185791394","kind":"news","pubTimestamp":1639108779,"share":"https://www.laohu8.com/m/news/1185791394?lang=zh_CN&edition=full","pubTime":"2021-12-10 11:59","market":"us","language":"en","title":"Palantir Stock May Be Down, But It’s Definitely Not Out<blockquote>Palantir股票可能下跌，但绝对没有出局</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1185791394","media":"InvestorPlace","summary":"There’s a school of thought that artificial intelligence and cybersecurity are a winning combination","content":"<p><div> There’s a school of thought that artificial intelligence and cybersecurity are a winning combination for a company to thrive in 2021. But Palantir Technologies(NYSE:PLTR) has defied that way of ...</p><p><blockquote><div>有一种观点认为，人工智能和网络安全是一家公司在2021年蓬勃发展的成功组合。但Palantir Technologies（纽约证券交易所股票代码：PLTR）却无视这种方式……</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/pltr-stock-may-be-down-but-its-definitely-not-out/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/pltr-stock-may-be-down-but-its-definitely-not-out/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Stock May Be Down, But It’s Definitely Not Out<blockquote>Palantir股票可能下跌，但绝对没有出局</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Stock May Be Down, But It’s Definitely Not Out<blockquote>Palantir股票可能下跌，但绝对没有出局</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-12-10 11:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> There’s a school of thought that artificial intelligence and cybersecurity are a winning combination for a company to thrive in 2021. But Palantir Technologies(NYSE:PLTR) has defied that way of ...</p><p><blockquote><div>有一种观点认为，人工智能和网络安全是一家公司在2021年蓬勃发展的成功组合。但Palantir Technologies（纽约证券交易所股票代码：PLTR）却无视这种方式……</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/pltr-stock-may-be-down-but-its-definitely-not-out/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/pltr-stock-may-be-down-but-its-definitely-not-out/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/12/pltr-stock-may-be-down-but-its-definitely-not-out/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://investorplace.com/2021/12/pltr-stock-may-be-down-but-its-definitely-not-out/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185791394","content_text":"There’s a school of thought that artificial intelligence and cybersecurity are a winning combination for a company to thrive in 2021. But Palantir Technologies(NYSE:PLTR) has defied that way of thinking as of late. PLTR stock has been a major disappointment for investors so far this year.\nSince hitting an all-time high of $45 in late January, shares of the big data analytics company are down roughly 57%. In the past month alone, PLTR stock is down nearly 28%.\nThat includes the post-earnings sell-off following the company’s third-quarter report, despite Palantir beating revenue expectations and delivering a strong outlook for the current quarter.\nCan PLTR stock turn its fortunes around in 2022? Let’s take a closer look.\nPalantir at a Glance\nFounded by Peter Thiel in 2003, Palantir Technologies went public via a direct listing in September 2020 and currently has a market cap of $38.8 billion. The company is headquartered in Denver and actually gets its name from J. R. R. Tolkien’s The Lord of the Rings series.“Palantiri” were magical and indestructible crystal balls that were used to communicate and see other parts of that fabled world.\nWhat Palantir does isn’t magical, but it is pretty cool. Palantir’s software allows government and private sector businesses to analyze and manage massive amounts of data, detecting meaningful patterns and connections. Its data sets are considered to be highly secure compared to its peers, which is why the company is sometimes considered a cybersecurity play.\nSome of Palantir’s first clients were U.S. intelligence agencies and the Pentagon. Over the past few years, the company has been growing its client base to include private firms, other federal agencies, and some state and local governments. For example, the U.S. Department of Health and Human Services uses Palantir software to track vaccine distribution.\nPalantir Delivers a Strong Q3 Earnings Report\nThe company’s third-quarter earnings report should have been a positive for PLTR stock. Palantir posted $392 million in revenue, while analysts had expected only $385 million. Earnings of 4 cents per share met expectations.\nRevenue was up 36% from the same quarter a year ago. However, some investors may have been disappointed as the previous two quarters saw 49% year-over-year growth.\nFor the fourth quarter, management expects revenue to increase 30% to $418 million, which was ahead of the consensus estimate of $402 million. Palantir projects full-year revenue of $1.53 billion, which would be a year-over-year increase of 40%. Through 2025, management believes it can grow revenue at least 30% annually.\nThe company used its earnings call to promote its new platform, Apollo, which it described as a new continuous delivery system that brings software-as-a-service (SaaS) management to its platforms. COO Shyam Sankar stated:\n\n Once again, we are building five years ahead of the market, software shamans building technology that will meet its moment. With our latest investments, you will be able to develop streaming pipelines in Foundry that you then package up, version, and continuously deploy to Edge compute infrastructure, be it a Humvee, a satellite, a 5G base station to enable real-time processing of large amounts of data in a decentralized efficient manner. These pipelines, they’ll be versioned, upgrade, managed, and orchestrated by Apollo.\n\nDespite the revenue beat and the promotion of the Apollo platform, PLTR stock fell by more than 9% immediately after the earnings report. And it has continued lower ever since. Some of that slide can be attributed to the market’s drag on tech stocks. But investors also appear concerned that Palantir is seeing slower growth.\nKeep an Eye on Recent Announcements\nWhile growth is slowing, investors should be cheered by a series of announcements that came out recently. These include:\n\nPalantir and Merck KGaA announced a partnership to address the global semiconductor shortage. The companies are developing an AI-infused platform that will help firms navigate the supply chain and reduce time to market.\nPalantir and Babylon Holdings(NYSE:BBLN) announced“substantial progress”on their work to use data to improve clinical care for Babylon’s healthcare clients.\nPalantir won a$43 million federal government contract with the Space Command’s Cross-Mission Ground & Communications Enterprise.\nPalantir and Kinder Morgan(NYSE:KMI) announced a multi-year deal in which Kinder Morgan will use Palantir’s platform to support its infrastructure and improve data analysis, grid integrity and pricing.\n\nAnd those are just the announcements from the past week or so. I expect similar headlines to continue to roll in.\nThe Bottom Line on PLTR Stock\nPLTR stock made a huge run higher into early January but has been struggling ever since. However, if you’re looking for a long-term cybersecurity and AI play, this is a solid pick. You’ll just have to be patient.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":2636,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602507366,"gmtCreate":1639037400366,"gmtModify":1639037576470,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602507366","repostId":"1134664549","repostType":4,"isVote":1,"tweetType":1,"viewCount":2312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606571272,"gmtCreate":1638913746881,"gmtModify":1638913783921,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606571272","repostId":"1140518037","repostType":4,"repost":{"id":"1140518037","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638890302,"share":"https://www.laohu8.com/m/news/1140518037?lang=zh_CN&edition=full","pubTime":"2021-12-07 23:18","market":"us","language":"en","title":"Network security stocks climbed in morning trading<blockquote>网络安全股早盘攀升</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1140518037","media":"Tiger Newspress","summary":"Network security stocks climbed in morning trading.SentinelOne,Fortinet,Zscaler,Cloudflare,CrowdStri","content":"<p>Network security stocks climbed in morning trading.SentinelOne,Fortinet,Zscaler,Cloudflare,CrowdStrike,Tenable,Palo Alto Networks,Mandiant&nbsp;and&nbsp;Cyberark&nbsp;rose&nbsp;between 3% and 15%.</p><p><blockquote>网络安全股早盘上涨。SentinelOne、Fortinet、Zscaler、Cloudflare、CrowdStrike、Tenable、Palo Alto Networks、Mandiant和Cyberark涨幅在3%至15%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8941cc27251bfb59578bccd3e5144ec1\" tg-width=\"406\" tg-height=\"543\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Network security stocks climbed in morning trading<blockquote>网络安全股早盘攀升</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetwork security stocks climbed in morning trading<blockquote>网络安全股早盘攀升</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-07 23:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Network security stocks climbed in morning trading.SentinelOne,Fortinet,Zscaler,Cloudflare,CrowdStrike,Tenable,Palo Alto Networks,Mandiant&nbsp;and&nbsp;Cyberark&nbsp;rose&nbsp;between 3% and 15%.</p><p><blockquote>网络安全股早盘上涨。SentinelOne、Fortinet、Zscaler、Cloudflare、CrowdStrike、Tenable、Palo Alto Networks、Mandiant和Cyberark涨幅在3%至15%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8941cc27251bfb59578bccd3e5144ec1\" tg-width=\"406\" tg-height=\"543\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZS":"Zscaler Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140518037","content_text":"Network security stocks climbed in morning trading.SentinelOne,Fortinet,Zscaler,Cloudflare,CrowdStrike,Tenable,Palo Alto Networks,Mandiant and Cyberark rose between 3% and 15%.","news_type":1,"symbols_score_info":{"ZS":0.9}},"isVote":1,"tweetType":1,"viewCount":2373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606949695,"gmtCreate":1638828986405,"gmtModify":1638829208912,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606949695","repostId":"1189410190","repostType":4,"repost":{"id":"1189410190","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638804387,"share":"https://www.laohu8.com/m/news/1189410190?lang=zh_CN&edition=full","pubTime":"2021-12-06 23:26","market":"us","language":"en","title":"Stocks linked to the reopening of the economy gained on Monday<blockquote>与经济重新开放相关的股票周一上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189410190","media":"Tiger Newspress","summary":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel book","content":"<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines&nbsp;and&nbsp;travel booking stocks&nbsp;jumped&nbsp;in morning trading.</p><p><blockquote>与经济重新开放相关的股票周一上涨。航空公司、邮轮公司和旅游预订股票在早盘交易中上涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks linked to the reopening of the economy gained on Monday<blockquote>与经济重新开放相关的股票周一上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks linked to the reopening of the economy gained on Monday<blockquote>与经济重新开放相关的股票周一上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 23:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines&nbsp;and&nbsp;travel booking stocks&nbsp;jumped&nbsp;in morning trading.</p><p><blockquote>与经济重新开放相关的股票周一上涨。航空公司、邮轮公司和旅游预订股票在早盘交易中上涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABNB":"爱彼迎","BA":"波音","ALK":"阿拉斯加航空集团有限公司","JBLU":"捷蓝航空","EXPE":"Expedia","CCL":"嘉年华邮轮","NCLH":"挪威邮轮","BKNG":"Booking Holdings","DAL":"达美航空","UAL":"联合大陆航空","RCL":"皇家加勒比邮轮","LUV":"西南航空","SAVE":"Spirit Airlines","AAL":"美国航空"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189410190","content_text":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.","news_type":1,"symbols_score_info":{"DAL":0.9,"LUV":0.9,"CCL":0.9,"BA":0.9,"UAL":0.9,"ALK":0.9,"NCLH":0.9,"AAL":0.9,"JBLU":0.9,"ABNB":0.9,"RCL":0.9,"SAVE":0.9,"BKNG":0.9,"EXPE":0.9}},"isVote":1,"tweetType":1,"viewCount":2205,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608670479,"gmtCreate":1638740117385,"gmtModify":1638740117496,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608670479","repostId":"2189557676","repostType":4,"isVote":1,"tweetType":1,"viewCount":2046,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608853811,"gmtCreate":1638688229024,"gmtModify":1638688229106,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608853811","repostId":"1140678193","repostType":4,"isVote":1,"tweetType":1,"viewCount":846,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601910235,"gmtCreate":1638480126627,"gmtModify":1638480126703,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601910235","repostId":"1100858196","repostType":4,"isVote":1,"tweetType":1,"viewCount":755,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603581600,"gmtCreate":1638427173584,"gmtModify":1638427327111,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603581600","repostId":"1107388817","repostType":4,"repost":{"id":"1107388817","kind":"news","pubTimestamp":1638425710,"share":"https://www.laohu8.com/m/news/1107388817?lang=zh_CN&edition=full","pubTime":"2021-12-02 14:15","market":"us","language":"en","title":"Salesforce Needs to Keep Having It Both Ways<blockquote>Salesforce需要保持两者兼得</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107388817","media":"WSJ","summary":"Salesforce.com found someone else to share the top job. It still won’t be an easy one.\nThe cloud sof","content":"<p>Salesforce.com found someone else to share the top job. It still won’t be an easy one.</p><p><blockquote>Salesforce.com找到了其他人来分担最高职位。这仍然不是一件容易的事。</blockquote></p><p> The cloud software pioneer’s fiscal third-quarter results late Tuesday included the news that Bret Taylor, who has been serving as the company’s president and chief operating officer since 2019, has been named co-CEO to work alongside longtime chief Marc Benioff. It is the company’s second attempt at the unusual leadership structure; the first lasted 18 months until co-CEO Keith Block left in February 2020.</p><p><blockquote>这家云软件先驱周二晚间公布的第三财季业绩包括自2019年以来一直担任该公司总裁兼首席运营官的布雷特·泰勒(Bret Taylor)被任命为联合首席执行官，与长期担任首席执行官的马克·贝尼奥夫(Marc Benioff)一起工作的消息。这是该公司对不同寻常的领导结构的第二次尝试；第一次持续了18个月，直到联合首席执行官基思·布洛克(Keith Block)于2020年2月离职。</blockquote></p><p> One might think Mr. Taylor was walking into a sweet gig. Salesforce shares have been on a tear of late, jumping 20% over the past six months and sharply outperforming cloud peers as the company’s strong financial performance helped investors shake off worries about the nearly $28 billion acquisition of Slack Technologies that was announced a year ago. But the company’s third-quarter results didn’t shine quite as brightly, with billings coming in slightly below Wall Street’s forecasts. Salesforce also projected revenue for the current quarter and the next one that was slightly below analysts’ projections. The company’s stock price slipped 6% following the results.</p><p><blockquote>有人可能会认为泰勒先生走进了一个甜蜜的工作。Salesforce股价最近大幅上涨，过去六个月上涨了20%，表现大幅优于云同行，因为该公司强劲的财务业绩帮助投资者摆脱了对一年前宣布的近280亿美元收购Slack Technologies的担忧。但该公司第三季度的业绩并没有那么亮眼，营收略低于华尔街的预期。Salesforce还预计本季度和下一季度的收入略低于分析师的预测。业绩公布后，该公司股价下跌6%。</blockquote></p><p> The reaction is a sign that investors are still adjusting to the new Salesforce. The company’s long focus on rapid growth has created an enterprise software giant now generating nearly $25 billion in annual revenue—a doubling in size in just three years. But investors seemed to tire of the growth-at-any-cost approach, as the company’s string of major acquisitions often put the stock into a funk. A sharper focus on improving profitability has thus resonated. Salesforce shares had jumped 10% since the company told analysts in September that adjusted operating margins would hit a record 20% in its fiscal year ending January of 2023.</p><p><blockquote>这种反应表明投资者仍在适应新的Salesforce。该公司长期以来对快速增长的关注造就了一家企业软件巨头，目前年收入近250亿美元，规模在短短三年内翻了一番。但投资者似乎厌倦了不惜一切代价实现增长的做法，因为该公司的一系列重大收购常常让该股陷入恐慌。因此，对提高盈利能力的更加关注引起了共鸣。自Salesforce 9月份告诉分析师调整后营业利润率将在截至2023年1月的财年达到创纪录的20%以来，该公司股价已上涨10%。</blockquote></p><p> The company stuck by that goal on Tuesday, despite the slightly weaker revenue picture for the near term. Changes brought about by the pandemic have allowed Salesforce to boost its efficiency; less corporate travel plus the near disappearance of massive in-person events like the company’s annual Dreamforce conference have helped sales and marketing expenses decline to 44% of revenue for the past nine months compared with the company’s average of 46% over the previous three fiscal years. And management is clearly expecting those changes to stick. Mr. Taylor told analysts Tuesday that “we all know we’re not going to be in the office five days a week.”</p><p><blockquote>尽管近期收入略有疲软，但该公司周二仍坚持这一目标。疫情带来的变化让Salesforce提高了效率；商务旅行的减少，加上公司年度Dreamforce会议等大型现场活动的几乎消失，帮助过去9个月的销售和营销费用占收入的比例下降至44%，而该公司前三个财年的平均比例为46%。管理层显然希望这些变化能够持续下去。泰勒先生周二告诉分析师，“我们都知道我们不会一周五天都在办公室。”</blockquote></p><p> But Salesforce still has to close a lot of sales if it wants to reach its goal of surpassing $30 billion in annual revenue in the next fiscal year. The jury remains out on whether the company can keep up that pace without resorting to bigger and more expensive acquisitions. The new, more-profitable Salesforce seems to be a hit with investors. A slower-growing one probably won’t be.</p><p><blockquote>但Salesforce若想在下一财年实现年收入超过300亿美元的目标，仍需完成大量销售。该公司能否在不诉诸更大、更昂贵的收购的情况下跟上这一步伐，目前还没有定论。新的、利润更高的Salesforce似乎受到了投资者的欢迎。增长较慢的可能不会。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Salesforce Needs to Keep Having It Both Ways<blockquote>Salesforce需要保持两者兼得</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSalesforce Needs to Keep Having It Both Ways<blockquote>Salesforce需要保持两者兼得</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">WSJ</strong><span class=\"h-time small\">2021-12-02 14:15</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Salesforce.com found someone else to share the top job. It still won’t be an easy one.</p><p><blockquote>Salesforce.com找到了其他人来分担最高职位。这仍然不是一件容易的事。</blockquote></p><p> The cloud software pioneer’s fiscal third-quarter results late Tuesday included the news that Bret Taylor, who has been serving as the company’s president and chief operating officer since 2019, has been named co-CEO to work alongside longtime chief Marc Benioff. It is the company’s second attempt at the unusual leadership structure; the first lasted 18 months until co-CEO Keith Block left in February 2020.</p><p><blockquote>这家云软件先驱周二晚间公布的第三财季业绩包括自2019年以来一直担任该公司总裁兼首席运营官的布雷特·泰勒(Bret Taylor)被任命为联合首席执行官，与长期担任首席执行官的马克·贝尼奥夫(Marc Benioff)一起工作的消息。这是该公司对不同寻常的领导结构的第二次尝试；第一次持续了18个月，直到联合首席执行官基思·布洛克(Keith Block)于2020年2月离职。</blockquote></p><p> One might think Mr. Taylor was walking into a sweet gig. Salesforce shares have been on a tear of late, jumping 20% over the past six months and sharply outperforming cloud peers as the company’s strong financial performance helped investors shake off worries about the nearly $28 billion acquisition of Slack Technologies that was announced a year ago. But the company’s third-quarter results didn’t shine quite as brightly, with billings coming in slightly below Wall Street’s forecasts. Salesforce also projected revenue for the current quarter and the next one that was slightly below analysts’ projections. The company’s stock price slipped 6% following the results.</p><p><blockquote>有人可能会认为泰勒先生走进了一个甜蜜的工作。Salesforce股价最近大幅上涨，过去六个月上涨了20%，表现大幅优于云同行，因为该公司强劲的财务业绩帮助投资者摆脱了对一年前宣布的近280亿美元收购Slack Technologies的担忧。但该公司第三季度的业绩并没有那么亮眼，营收略低于华尔街的预期。Salesforce还预计本季度和下一季度的收入略低于分析师的预测。业绩公布后，该公司股价下跌6%。</blockquote></p><p> The reaction is a sign that investors are still adjusting to the new Salesforce. The company’s long focus on rapid growth has created an enterprise software giant now generating nearly $25 billion in annual revenue—a doubling in size in just three years. But investors seemed to tire of the growth-at-any-cost approach, as the company’s string of major acquisitions often put the stock into a funk. A sharper focus on improving profitability has thus resonated. Salesforce shares had jumped 10% since the company told analysts in September that adjusted operating margins would hit a record 20% in its fiscal year ending January of 2023.</p><p><blockquote>这种反应表明投资者仍在适应新的Salesforce。该公司长期以来对快速增长的关注造就了一家企业软件巨头，目前年收入近250亿美元，规模在短短三年内翻了一番。但投资者似乎厌倦了不惜一切代价实现增长的做法，因为该公司的一系列重大收购常常让该股陷入恐慌。因此，对提高盈利能力的更加关注引起了共鸣。自Salesforce 9月份告诉分析师调整后营业利润率将在截至2023年1月的财年达到创纪录的20%以来，该公司股价已上涨10%。</blockquote></p><p> The company stuck by that goal on Tuesday, despite the slightly weaker revenue picture for the near term. Changes brought about by the pandemic have allowed Salesforce to boost its efficiency; less corporate travel plus the near disappearance of massive in-person events like the company’s annual Dreamforce conference have helped sales and marketing expenses decline to 44% of revenue for the past nine months compared with the company’s average of 46% over the previous three fiscal years. And management is clearly expecting those changes to stick. Mr. Taylor told analysts Tuesday that “we all know we’re not going to be in the office five days a week.”</p><p><blockquote>尽管近期收入略有疲软，但该公司周二仍坚持这一目标。疫情带来的变化让Salesforce提高了效率；商务旅行的减少，加上公司年度Dreamforce会议等大型现场活动的几乎消失，帮助过去9个月的销售和营销费用占收入的比例下降至44%，而该公司前三个财年的平均比例为46%。管理层显然希望这些变化能够持续下去。泰勒先生周二告诉分析师，“我们都知道我们不会一周五天都在办公室。”</blockquote></p><p> But Salesforce still has to close a lot of sales if it wants to reach its goal of surpassing $30 billion in annual revenue in the next fiscal year. The jury remains out on whether the company can keep up that pace without resorting to bigger and more expensive acquisitions. The new, more-profitable Salesforce seems to be a hit with investors. A slower-growing one probably won’t be.</p><p><blockquote>但Salesforce若想在下一财年实现年收入超过300亿美元的目标，仍需完成大量销售。该公司能否在不诉诸更大、更昂贵的收购的情况下跟上这一步伐，目前还没有定论。新的、利润更高的Salesforce似乎受到了投资者的欢迎。增长较慢的可能不会。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/salesforce-needs-to-keep-having-it-both-ways-11638363601?mod=business_major_pos12\">WSJ</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRM":"赛富时"},"source_url":"https://www.wsj.com/articles/salesforce-needs-to-keep-having-it-both-ways-11638363601?mod=business_major_pos12","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107388817","content_text":"Salesforce.com found someone else to share the top job. It still won’t be an easy one.\nThe cloud software pioneer’s fiscal third-quarter results late Tuesday included the news that Bret Taylor, who has been serving as the company’s president and chief operating officer since 2019, has been named co-CEO to work alongside longtime chief Marc Benioff. It is the company’s second attempt at the unusual leadership structure; the first lasted 18 months until co-CEO Keith Block left in February 2020.\nOne might think Mr. Taylor was walking into a sweet gig. Salesforce shares have been on a tear of late, jumping 20% over the past six months and sharply outperforming cloud peers as the company’s strong financial performance helped investors shake off worries about the nearly $28 billion acquisition of Slack Technologies that was announced a year ago. But the company’s third-quarter results didn’t shine quite as brightly, with billings coming in slightly below Wall Street’s forecasts. Salesforce also projected revenue for the current quarter and the next one that was slightly below analysts’ projections. The company’s stock price slipped 6% following the results.\nThe reaction is a sign that investors are still adjusting to the new Salesforce. The company’s long focus on rapid growth has created an enterprise software giant now generating nearly $25 billion in annual revenue—a doubling in size in just three years. But investors seemed to tire of the growth-at-any-cost approach, as the company’s string of major acquisitions often put the stock into a funk. A sharper focus on improving profitability has thus resonated. Salesforce shares had jumped 10% since the company told analysts in September that adjusted operating margins would hit a record 20% in its fiscal year ending January of 2023.\nThe company stuck by that goal on Tuesday, despite the slightly weaker revenue picture for the near term. Changes brought about by the pandemic have allowed Salesforce to boost its efficiency; less corporate travel plus the near disappearance of massive in-person events like the company’s annual Dreamforce conference have helped sales and marketing expenses decline to 44% of revenue for the past nine months compared with the company’s average of 46% over the previous three fiscal years. And management is clearly expecting those changes to stick. Mr. Taylor told analysts Tuesday that “we all know we’re not going to be in the office five days a week.”\nBut Salesforce still has to close a lot of sales if it wants to reach its goal of surpassing $30 billion in annual revenue in the next fiscal year. The jury remains out on whether the company can keep up that pace without resorting to bigger and more expensive acquisitions. The new, more-profitable Salesforce seems to be a hit with investors. A slower-growing one probably won’t be.","news_type":1,"symbols_score_info":{"CRM":0.9}},"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603355988,"gmtCreate":1638369422487,"gmtModify":1638369422711,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603355988","repostId":"1100878233","repostType":4,"isVote":1,"tweetType":1,"viewCount":790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609081502,"gmtCreate":1638221185250,"gmtModify":1638221185481,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609081502","repostId":"1129736600","repostType":4,"repost":{"id":"1129736600","kind":"news","pubTimestamp":1638148434,"share":"https://www.laohu8.com/m/news/1129736600?lang=zh_CN&edition=full","pubTime":"2021-11-29 09:13","market":"us","language":"en","title":"Tesla’s Elon Musk sends another email. What it means for fourth-quarter earnings.<blockquote>特斯拉的Elon Musk又发了一封邮件。这对第四季度收益意味着什么。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1129736600","media":"Barrons","summary":"Tesla CEO Elon Musk warned employees in a recent email the electric vehicle maker shouldn’t be spending irresponsibly in the final weeks of the year to meet a quarter-end delivery rush. The reason seems sensible, even if his call might vex investors.Musk wants to minimize the cost of fourth quarter deliveries. He doesn’t see a reason for Tesla  to overspend for a few weeks of any quarter only to see deliveries numbers crash in the first few weeks of the following quarter. It isn’t an optimal cyc","content":"<p>Tesla CEO Elon Musk warned employees in a recent email the electric vehicle maker shouldn’t be spending irresponsibly in the final weeks of the year to meet a quarter-end delivery rush. The reason seems sensible, even if his call might vex investors.</p><p><blockquote>特斯拉首席执行官Elon Musk在最近的一封电子邮件中警告员工，这家电动汽车制造商不应该在今年最后几周不负责任地花钱来应对季度末的交付高峰。这个理由似乎很合理，即使他的看涨期权可能会惹恼投资者。</blockquote></p><p> Musk wants to minimize the cost of fourth quarter deliveries. He doesn’t see a reason for Tesla (ticker: TSLA) to overspend for a few weeks of any quarter only to see deliveries numbers crash in the first few weeks of the following quarter. It isn’t an optimal cycle for work or spending.</p><p><blockquote>马斯克希望将第四季度的交付成本降至最低。他认为特斯拉（股票代码：TSLA）没有理由在任何季度的几周内超支，却在下一季度的前几周看到交付量暴跌。这不是工作或支出的最佳周期。</blockquote></p><p> “Looked at over a six month period, we won’t have any extra cars, but we would have spent a lot of extra money and burned ourselves out to accelerate deliveries in the last two weeks of each quarter,” reads the email. “This is [the] right time to start reducing the size of the wave in favor of a steadier and more efficient pace of deliveries.”</p><p><blockquote>电子邮件中写道：“从六个月的时间来看，我们不会有任何额外的汽车，但我们会花费大量额外的钱，并在每个季度的最后两周竭尽全力加快交付速度。”“现在是开始缩小浪潮规模以实现更稳定、更高效的交付速度的最佳时机。”</blockquote></p><p> It might be the right time because Tesla is going from having two plants producing cars to four plants. More assembly capacity might make it easier to manage the pace of deliveries in coming quarters.</p><p><blockquote>这可能是正确的时机，因为特斯拉将从拥有两家生产汽车的工厂增加到四家工厂。更多的组装能力可能会更容易管理未来几个季度的交付速度。</blockquote></p><p> Investors, of course, want big delivery numbers and big earnings. And breaking the pattern of big end-of-quarter deliveries could cause some unwanted stock volatility when fourth quarter deliveries are reported in the early days of the new year.</p><p><blockquote>当然，投资者想要大的交付数量和大的收益。当新年伊始报告第四季度交付量时，打破季度末交付量大的模式可能会导致一些不必要的库存波动。</blockquote></p><p> Still, Musk is setting expectations early and the change should be a one quarter impact — if the delivery pattern is smoothed out like Musk suggests.</p><p><blockquote>尽管如此，马斯克很早就设定了预期，如果交付模式像马斯克建议的那样顺利的话，这一变化应该会影响一个季度。</blockquote></p><p> What’s more, investors can’t really assume the change will lead to bad delivery numbers or disappointing earnings. Musk might have decided to send the email because delivery numbers are looking solid. There is just no way to know. Tesla didn’t respond to a request for comment on Sunday.</p><p><blockquote>更重要的是，投资者不能真正假设这一变化会导致糟糕的交付数字或令人失望的收益。马斯克可能决定发送这封电子邮件，因为交付数量看起来很稳定。只是没有办法知道。特斯拉周日没有回应置评请求。</blockquote></p><p> It’s also possible that automotive profit margins will improve if Tesla is spending less to deliver vehicles. That will be something to watch for when Tesla reports forth quarter earnings around the end of January 2022.</p><p><blockquote>如果特斯拉减少车辆交付支出，汽车利润率也有可能提高。当特斯拉在2022年1月底左右报告第四季度收益时，这将是值得关注的事情。</blockquote></p><p> Wall Street is looking for 266,000 vehicles delivered for the fourth quarter. That would be a record and bring full year 2021 deliveries to just less than 900,000. Tesla delivered about 500,000 vehicles in 2020.</p><p><blockquote>华尔街预计第四季度交付266,000辆汽车。这将创下纪录，使2021年全年交付量略低于90万辆。特斯拉在2020年交付了约50万辆汽车。</blockquote></p><p> The recent delivery email follows after another email sent by Musk to managers that detailed how he expects managers to react to his comments. In it Musk said managers could request clarification of his written instructions, among other things. The newer email, however, seems clear.</p><p><blockquote>在最近的交付电子邮件之前，马斯克向经理们发送了另一封电子邮件，详细说明了他希望经理们如何对他的评论做出反应。马斯克在信中表示，经理们可以要求澄清他的书面指示等。然而，新的电子邮件似乎很清楚。</blockquote></p><p> Coming into Monday trading, Tesla stock is up about 53% year to date, better than the 22% and 14% comparable, respective returns of the S&amp;P 500 and Dow Jones Industrial Average.</p><p><blockquote>截至周一交易，特斯拉股价今年迄今已上涨约53%，好于标普500和道琼斯工业平均指数分别22%和14%的可比回报率。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla’s Elon Musk sends another email. What it means for fourth-quarter earnings.<blockquote>特斯拉的Elon Musk又发了一封邮件。这对第四季度收益意味着什么。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla’s Elon Musk sends another email. What it means for fourth-quarter earnings.<blockquote>特斯拉的Elon Musk又发了一封邮件。这对第四季度收益意味着什么。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-29 09:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tesla CEO Elon Musk warned employees in a recent email the electric vehicle maker shouldn’t be spending irresponsibly in the final weeks of the year to meet a quarter-end delivery rush. The reason seems sensible, even if his call might vex investors.</p><p><blockquote>特斯拉首席执行官Elon Musk在最近的一封电子邮件中警告员工，这家电动汽车制造商不应该在今年最后几周不负责任地花钱来应对季度末的交付高峰。这个理由似乎很合理，即使他的看涨期权可能会惹恼投资者。</blockquote></p><p> Musk wants to minimize the cost of fourth quarter deliveries. He doesn’t see a reason for Tesla (ticker: TSLA) to overspend for a few weeks of any quarter only to see deliveries numbers crash in the first few weeks of the following quarter. It isn’t an optimal cycle for work or spending.</p><p><blockquote>马斯克希望将第四季度的交付成本降至最低。他认为特斯拉（股票代码：TSLA）没有理由在任何季度的几周内超支，却在下一季度的前几周看到交付量暴跌。这不是工作或支出的最佳周期。</blockquote></p><p> “Looked at over a six month period, we won’t have any extra cars, but we would have spent a lot of extra money and burned ourselves out to accelerate deliveries in the last two weeks of each quarter,” reads the email. “This is [the] right time to start reducing the size of the wave in favor of a steadier and more efficient pace of deliveries.”</p><p><blockquote>电子邮件中写道：“从六个月的时间来看，我们不会有任何额外的汽车，但我们会花费大量额外的钱，并在每个季度的最后两周竭尽全力加快交付速度。”“现在是开始缩小浪潮规模以实现更稳定、更高效的交付速度的最佳时机。”</blockquote></p><p> It might be the right time because Tesla is going from having two plants producing cars to four plants. More assembly capacity might make it easier to manage the pace of deliveries in coming quarters.</p><p><blockquote>这可能是正确的时机，因为特斯拉将从拥有两家生产汽车的工厂增加到四家工厂。更多的组装能力可能会更容易管理未来几个季度的交付速度。</blockquote></p><p> Investors, of course, want big delivery numbers and big earnings. And breaking the pattern of big end-of-quarter deliveries could cause some unwanted stock volatility when fourth quarter deliveries are reported in the early days of the new year.</p><p><blockquote>当然，投资者想要大的交付数量和大的收益。当新年伊始报告第四季度交付量时，打破季度末交付量大的模式可能会导致一些不必要的库存波动。</blockquote></p><p> Still, Musk is setting expectations early and the change should be a one quarter impact — if the delivery pattern is smoothed out like Musk suggests.</p><p><blockquote>尽管如此，马斯克很早就设定了预期，如果交付模式像马斯克建议的那样顺利的话，这一变化应该会影响一个季度。</blockquote></p><p> What’s more, investors can’t really assume the change will lead to bad delivery numbers or disappointing earnings. Musk might have decided to send the email because delivery numbers are looking solid. There is just no way to know. Tesla didn’t respond to a request for comment on Sunday.</p><p><blockquote>更重要的是，投资者不能真正假设这一变化会导致糟糕的交付数字或令人失望的收益。马斯克可能决定发送这封电子邮件，因为交付数量看起来很稳定。只是没有办法知道。特斯拉周日没有回应置评请求。</blockquote></p><p> It’s also possible that automotive profit margins will improve if Tesla is spending less to deliver vehicles. That will be something to watch for when Tesla reports forth quarter earnings around the end of January 2022.</p><p><blockquote>如果特斯拉减少车辆交付支出，汽车利润率也有可能提高。当特斯拉在2022年1月底左右报告第四季度收益时，这将是值得关注的事情。</blockquote></p><p> Wall Street is looking for 266,000 vehicles delivered for the fourth quarter. That would be a record and bring full year 2021 deliveries to just less than 900,000. Tesla delivered about 500,000 vehicles in 2020.</p><p><blockquote>华尔街预计第四季度交付266,000辆汽车。这将创下纪录，使2021年全年交付量略低于90万辆。特斯拉在2020年交付了约50万辆汽车。</blockquote></p><p> The recent delivery email follows after another email sent by Musk to managers that detailed how he expects managers to react to his comments. In it Musk said managers could request clarification of his written instructions, among other things. The newer email, however, seems clear.</p><p><blockquote>在最近的交付电子邮件之前，马斯克向经理们发送了另一封电子邮件，详细说明了他希望经理们如何对他的评论做出反应。马斯克在信中表示，经理们可以要求澄清他的书面指示等。然而，新的电子邮件似乎很清楚。</blockquote></p><p> Coming into Monday trading, Tesla stock is up about 53% year to date, better than the 22% and 14% comparable, respective returns of the S&amp;P 500 and Dow Jones Industrial Average.</p><p><blockquote>截至周一交易，特斯拉股价今年迄今已上涨约53%，好于标普500和道琼斯工业平均指数分别22%和14%的可比回报率。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/teslas-elon-musk-email-what-it-means-51638119355?mod=hp_DAY_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/teslas-elon-musk-email-what-it-means-51638119355?mod=hp_DAY_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129736600","content_text":"Tesla CEO Elon Musk warned employees in a recent email the electric vehicle maker shouldn’t be spending irresponsibly in the final weeks of the year to meet a quarter-end delivery rush. The reason seems sensible, even if his call might vex investors.\nMusk wants to minimize the cost of fourth quarter deliveries. He doesn’t see a reason for Tesla (ticker: TSLA) to overspend for a few weeks of any quarter only to see deliveries numbers crash in the first few weeks of the following quarter. It isn’t an optimal cycle for work or spending.\n“Looked at over a six month period, we won’t have any extra cars, but we would have spent a lot of extra money and burned ourselves out to accelerate deliveries in the last two weeks of each quarter,” reads the email. “This is [the] right time to start reducing the size of the wave in favor of a steadier and more efficient pace of deliveries.”\nIt might be the right time because Tesla is going from having two plants producing cars to four plants. More assembly capacity might make it easier to manage the pace of deliveries in coming quarters.\nInvestors, of course, want big delivery numbers and big earnings. And breaking the pattern of big end-of-quarter deliveries could cause some unwanted stock volatility when fourth quarter deliveries are reported in the early days of the new year.\nStill, Musk is setting expectations early and the change should be a one quarter impact — if the delivery pattern is smoothed out like Musk suggests.\nWhat’s more, investors can’t really assume the change will lead to bad delivery numbers or disappointing earnings. Musk might have decided to send the email because delivery numbers are looking solid. There is just no way to know. Tesla didn’t respond to a request for comment on Sunday.\nIt’s also possible that automotive profit margins will improve if Tesla is spending less to deliver vehicles. That will be something to watch for when Tesla reports forth quarter earnings around the end of January 2022.\nWall Street is looking for 266,000 vehicles delivered for the fourth quarter. That would be a record and bring full year 2021 deliveries to just less than 900,000. Tesla delivered about 500,000 vehicles in 2020.\nThe recent delivery email follows after another email sent by Musk to managers that detailed how he expects managers to react to his comments. In it Musk said managers could request clarification of his written instructions, among other things. The newer email, however, seems clear.\nComing into Monday trading, Tesla stock is up about 53% year to date, better than the 22% and 14% comparable, respective returns of the S&P 500 and Dow Jones Industrial Average.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600980244,"gmtCreate":1638051630843,"gmtModify":1638051630980,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600980244","repostId":"2186344334","repostType":4,"isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877578705,"gmtCreate":1637965106918,"gmtModify":1637965106986,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877578705","repostId":"1158420182","repostType":4,"repost":{"id":"1158420182","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637939738,"share":"https://www.laohu8.com/m/news/1158420182?lang=zh_CN&edition=full","pubTime":"2021-11-26 23:15","market":"fut","language":"en","title":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158420182","media":"Tiger Newspress","summary":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.","content":"<p>WTI crude tumbled&nbsp;9.02% to $71.28 a barrel,&nbsp;Brent&nbsp;fell&nbsp;8.16%.<img src=\"https://static.tigerbbs.com/6e118e6a5e909412e48ca104b2c37b30\" tg-width=\"884\" tg-height=\"611\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/1ac1680f3b9d8085d5fd9b6a868ce9c3\" tg-width=\"870\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-26 23:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>WTI crude tumbled&nbsp;9.02% to $71.28 a barrel,&nbsp;Brent&nbsp;fell&nbsp;8.16%.<img src=\"https://static.tigerbbs.com/6e118e6a5e909412e48ca104b2c37b30\" tg-width=\"884\" tg-height=\"611\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/1ac1680f3b9d8085d5fd9b6a868ce9c3\" tg-width=\"870\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote>WTI原油下跌9.02%至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158420182","content_text":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.","news_type":1,"symbols_score_info":{"CLmain":0.9,"BZmain":0.9}},"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877268094,"gmtCreate":1637936893745,"gmtModify":1637936893811,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877268094","repostId":"1116442909","repostType":4,"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874219877,"gmtCreate":1637789572022,"gmtModify":1637789572133,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874219877","repostId":"1127412420","repostType":4,"repost":{"id":"1127412420","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637766895,"share":"https://www.laohu8.com/m/news/1127412420?lang=zh_CN&edition=full","pubTime":"2021-11-24 23:14","market":"us","language":"en","title":"Mastercard shares rose nearly 1% in early trading<blockquote>万事达卡股价早盘上涨近1%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1127412420","media":"Tiger Newspress","summary":"Mastercard shares rose nearly 1% in early trading.\nMastercard has acquired Arcus FI, an alum of the ","content":"<p>Mastercard&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;1%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/d4d967747245d09157c86522947b6132\" tg-width=\"874\" tg-height=\"599\" width=\"100%\" height=\"auto\"></p><p><blockquote>万事达卡股价早盘上涨近1%。</blockquote></p><p> Mastercard&nbsp;has&nbsp;acquired&nbsp;Arcus FI, an alum of the company’s Start Path program, to help support the delivery of bill pay solutions and other real-time payment applications across&nbsp;Latin America.</p><p><blockquote>万事达卡收购了该公司Start Path计划的校友Arcus FI，以帮助支持在拉丁美洲交付账单支付解决方案和其他实时支付应用程序。</blockquote></p><p> Arcus helps to enable bill pay and cash-in, cash-out services for some of the biggest billers, retailers, fintechs and traditional financial institutions in the&nbsp;U.S.&nbsp;and&nbsp;Mexico, with expansion into&nbsp;Latin America.</p><p><blockquote>Arcus帮助美国和墨西哥一些最大的账单支付商、零售商、金融科技公司和传统金融机构实现账单支付和现金进出服务，并扩展到拉丁美洲。</blockquote></p><p> Arcus Pay Network, has access to the largest retailers and direct connection with many of the largest billers in&nbsp;Mexico.</p><p><blockquote>Arcus Pay Network可以接触到墨西哥最大的零售商，并与许多最大的账单机构直接联系。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mastercard shares rose nearly 1% in early trading<blockquote>万事达卡股价早盘上涨近1%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMastercard shares rose nearly 1% in early trading<blockquote>万事达卡股价早盘上涨近1%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-24 23:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Mastercard&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;1%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/d4d967747245d09157c86522947b6132\" tg-width=\"874\" tg-height=\"599\" width=\"100%\" height=\"auto\"></p><p><blockquote>万事达卡股价早盘上涨近1%。</blockquote></p><p> Mastercard&nbsp;has&nbsp;acquired&nbsp;Arcus FI, an alum of the company’s Start Path program, to help support the delivery of bill pay solutions and other real-time payment applications across&nbsp;Latin America.</p><p><blockquote>万事达卡收购了该公司Start Path计划的校友Arcus FI，以帮助支持在拉丁美洲交付账单支付解决方案和其他实时支付应用程序。</blockquote></p><p> Arcus helps to enable bill pay and cash-in, cash-out services for some of the biggest billers, retailers, fintechs and traditional financial institutions in the&nbsp;U.S.&nbsp;and&nbsp;Mexico, with expansion into&nbsp;Latin America.</p><p><blockquote>Arcus帮助美国和墨西哥一些最大的账单支付商、零售商、金融科技公司和传统金融机构实现账单支付和现金进出服务，并扩展到拉丁美洲。</blockquote></p><p> Arcus Pay Network, has access to the largest retailers and direct connection with many of the largest billers in&nbsp;Mexico.</p><p><blockquote>Arcus Pay Network可以接触到墨西哥最大的零售商，并与许多最大的账单机构直接联系。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MA":"万事达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127412420","content_text":"Mastercard shares rose nearly 1% in early trading.\nMastercard has acquired Arcus FI, an alum of the company’s Start Path program, to help support the delivery of bill pay solutions and other real-time payment applications across Latin America.\nArcus helps to enable bill pay and cash-in, cash-out services for some of the biggest billers, retailers, fintechs and traditional financial institutions in the U.S. and Mexico, with expansion into Latin America.\nArcus Pay Network, has access to the largest retailers and direct connection with many of the largest billers in Mexico.","news_type":1,"symbols_score_info":{"MA":0.9}},"isVote":1,"tweetType":1,"viewCount":588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875724003,"gmtCreate":1637702850233,"gmtModify":1637702878502,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560475301779740","authorIdStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875724003","repostId":"1117658681","repostType":4,"repost":{"id":"1117658681","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637681053,"share":"https://www.laohu8.com/m/news/1117658681?lang=zh_CN&edition=full","pubTime":"2021-11-23 23:24","market":"us","language":"en","title":"XPeng shares rose nearly 12% in early trading<blockquote>小鹏汽车股价早盘涨近12%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1117658681","media":"Tiger Newspress","summary":"XPeng shares rose nearly 12% in early trading after the China-based electric vehicle maker reported ","content":"<p>XPeng&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading&nbsp;after the China-based electric vehicle maker reported a wider-than-expected third-quarter loss but revenue that rose well above forecasts and provided an upbeat fourth-quarter outlook.<img src=\"https://static.tigerbbs.com/a8d43127b29dfc54fadaa9e23939d911\" tg-width=\"878\" tg-height=\"596\" referrerpolicy=\"no-referrer\">The net loss widened to RMB1.59 bln ($249.7 million), or RMB1.89 per American depositary share (ADS), from a loss of RMB1.15 billion a year ago. Excluding nonrecurring items, the adjusted loss per ADS came to RMB1.77, compared with the FactSet consensus of RMB1.30.</p><p><blockquote>小鹏汽车股价早盘上涨近12%，此前这家中国电动汽车制造商公布第三季度亏损超出预期，但收入增幅远高于预期，并提供了乐观的第四季度前景。净亏损从一年前的亏损11.5亿元人民币扩大至15.9亿元人民币（2.497亿美元），即每股美国存托股票(ADS)1.89元人民币。不包括非经常性项目，调整后每股美国存托凭证亏损为人民币1.77元，而FactSet共识为人民币1.30元。</blockquote></p><p> Revenue jumps 187.4% to RMB5.72 billion ($895.5 million) to beat the FactSet consensus of RMB5.03 billion, as deliveries rose 199.2% to a record 25,666 vehicles, including 217.7% growth in P7 model deliveries.</p><p><blockquote>收入增长187.4%，达到人民币57.2亿元（8.955亿美元），超过FactSet预期的人民币50.3亿元，交付量增长199.2%，达到创纪录的25,666辆，其中P7车型交付量增长217.7%。</blockquote></p><p> Gross margin improved to 14.4% from 4.6%. Looking ahead, the company expects fourth-quarter deliveries of between 34,500 and 36,500 vehicles, representing growth of 166.1% to 181.5%, and revenue between RMB7.1 billion and RMB7.5 billion, compared with the FactSet consensus of RMB6.09 billion.</p><p><blockquote>毛利率从4.6%提高至14.4%。展望未来，该公司预计第四季度交付量将在34,500辆至36,500辆之间，增长166.1%至181.5%，收入将在人民币71亿元至人民币75亿元之间，而FactSet共识为人民币60.9亿元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XPeng shares rose nearly 12% in early trading<blockquote>小鹏汽车股价早盘涨近12%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXPeng shares rose nearly 12% in early trading<blockquote>小鹏汽车股价早盘涨近12%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-23 23:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>XPeng&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading&nbsp;after the China-based electric vehicle maker reported a wider-than-expected third-quarter loss but revenue that rose well above forecasts and provided an upbeat fourth-quarter outlook.<img src=\"https://static.tigerbbs.com/a8d43127b29dfc54fadaa9e23939d911\" tg-width=\"878\" tg-height=\"596\" referrerpolicy=\"no-referrer\">The net loss widened to RMB1.59 bln ($249.7 million), or RMB1.89 per American depositary share (ADS), from a loss of RMB1.15 billion a year ago. Excluding nonrecurring items, the adjusted loss per ADS came to RMB1.77, compared with the FactSet consensus of RMB1.30.</p><p><blockquote>小鹏汽车股价早盘上涨近12%，此前这家中国电动汽车制造商公布第三季度亏损超出预期，但收入增幅远高于预期，并提供了乐观的第四季度前景。净亏损从一年前的亏损11.5亿元人民币扩大至15.9亿元人民币（2.497亿美元），即每股美国存托股票(ADS)1.89元人民币。不包括非经常性项目，调整后每股美国存托凭证亏损为人民币1.77元，而FactSet共识为人民币1.30元。</blockquote></p><p> Revenue jumps 187.4% to RMB5.72 billion ($895.5 million) to beat the FactSet consensus of RMB5.03 billion, as deliveries rose 199.2% to a record 25,666 vehicles, including 217.7% growth in P7 model deliveries.</p><p><blockquote>收入增长187.4%，达到人民币57.2亿元（8.955亿美元），超过FactSet预期的人民币50.3亿元，交付量增长199.2%，达到创纪录的25,666辆，其中P7车型交付量增长217.7%。</blockquote></p><p> Gross margin improved to 14.4% from 4.6%. Looking ahead, the company expects fourth-quarter deliveries of between 34,500 and 36,500 vehicles, representing growth of 166.1% to 181.5%, and revenue between RMB7.1 billion and RMB7.5 billion, compared with the FactSet consensus of RMB6.09 billion.</p><p><blockquote>毛利率从4.6%提高至14.4%。展望未来，该公司预计第四季度交付量将在34,500辆至36,500辆之间，增长166.1%至181.5%，收入将在人民币71亿元至人民币75亿元之间，而FactSet共识为人民币60.9亿元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09868":"小鹏汽车-W","XPEV":"小鹏汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117658681","content_text":"XPeng shares rose nearly 12% in early trading after the China-based electric vehicle maker reported a wider-than-expected third-quarter loss but revenue that rose well above forecasts and provided an upbeat fourth-quarter outlook.The net loss widened to RMB1.59 bln ($249.7 million), or RMB1.89 per American depositary share (ADS), from a loss of RMB1.15 billion a year ago. Excluding nonrecurring items, the adjusted loss per ADS came to RMB1.77, compared with the FactSet consensus of RMB1.30.\nRevenue jumps 187.4% to RMB5.72 billion ($895.5 million) to beat the FactSet consensus of RMB5.03 billion, as deliveries rose 199.2% to a record 25,666 vehicles, including 217.7% growth in P7 model deliveries.\nGross margin improved to 14.4% from 4.6%. Looking ahead, the company expects fourth-quarter deliveries of between 34,500 and 36,500 vehicles, representing growth of 166.1% to 181.5%, and revenue between RMB7.1 billion and RMB7.5 billion, compared with the FactSet consensus of RMB6.09 billion.","news_type":1,"symbols_score_info":{"09868":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":895504442,"gmtCreate":1628753628286,"gmtModify":1633689762420,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/895504442","repostId":"1166105319","repostType":4,"isVote":1,"tweetType":1,"viewCount":290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":607276932,"gmtCreate":1639553942521,"gmtModify":1639553942651,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607276932","repostId":"1107549050","repostType":4,"repost":{"id":"1107549050","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639552499,"share":"https://www.laohu8.com/m/news/1107549050?lang=zh_CN&edition=full","pubTime":"2021-12-15 15:14","market":"us","language":"en","title":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation<blockquote>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107549050","media":"Tiger Newspress","summary":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and c","content":"<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p><p><blockquote><b>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</b></blockquote></p><p> <ul>  <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>  <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>  <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li> </ul> Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p><p><blockquote><ul><li>阳性加强剂数据显示，接受的所有初级疫苗（mRNA或腺病毒）中的中和抗体增加了9至43倍，并且对于所有测试的年龄组，具有良好的安全性和耐受性</li><li>随着世界各地的人群越来越多地暴露于新冠肺炎变种，3期试验继续增加分析所需的事件数量；预计2022年第一季度业绩</li><li>公司打算在第三阶段结果公布后向监管机构提交加强数据</li></ul>赛诺菲和葛兰素史克今天宣布，他们的重组佐剂新冠肺炎候选疫苗的单次加强剂量产生了持续强烈的免疫反应。调查加强剂安全性和免疫原性的VAT0002临床试验的初步结果显示，无论接受的初级疫苗（阿斯利康、强生、Moderna、辉瑞/BioNTech）和所有测试年龄组，中和抗体都增加了9至43倍。加强剂耐受性良好，安全性与目前批准的新冠肺炎疫苗相似。这是迄今为止最全面的加强试验，旨在探索用于初级疫苗接种的不同疫苗技术的加强。</blockquote></p><p> The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p><p><blockquote>正在进行的全球3期试验VAT0008包括独立数据安全监测委员会(DSMB)的定期审查。在上次审查中，DSMB没有发现任何安全问题，并建议试验继续到2022年初，以积累更多数据。</blockquote></p><p> Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p><p><blockquote>监管机构要求在“幼稚”人群中证明3期疗效，即从未感染过新冠肺炎病毒（血清阴性）的参与者。3期试验在2021年第三季度招募了大多数参与者，恰逢德尔塔变异毒株导致全球感染COVID-19病毒的人数大幅增加。为了向监管机构提供加强疫苗提交所需的数据，该试验将继续累积分析所需的事件数量，预计将于2022年第一季度得出结果。</blockquote></p><p> <i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p><p><blockquote><i>“这些初步数据表明，无论您接种的是什么初级疫苗，我们都有一种强大的加强候选疫苗。”</i>赛诺菲巴斯德执行副总裁Thomas Triomphe说道。<i>“这与我们为不断变化的公共卫生需求提供相关响应的努力是一致的。虽然在快速变化的大流行环境中进行3期试验是一项挑战，但我们期待看到结果，以支持尽快提交我们的加强疫苗。”</i></blockquote></p><p> Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p><p><blockquote>葛兰素史克疫苗总裁罗杰·康纳补充道<i>：“随着大流行威胁的持续，目前占主导地位的德尔塔变异毒株和奥密克戎迅速取得进展，随着时间的推移，将继续需要加强疫苗来帮助保护人们。最初的加强数据很有希望，我们正在等待III期结果，以确定提供基于蛋白质的佐剂COVID-19疫苗的下一步措施。”</i></blockquote></p><p> In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p><p><blockquote>与此同时，赛诺菲继续为全球公共卫生需求做出贡献，生产了多达5亿剂BioNTech/辉瑞、Moderna和强生疫苗。</blockquote></p><p> <b>About the booster trial (VAT0002)</b></p><p><blockquote><b>关于加强试验（VAT0002）</b></blockquote></p><p> The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p><p><blockquote>VAT0002扩展试验是迄今为止进行的最全面的异源加强试验。在该试验的第一个队列中，使用mRNA和腺病毒载体技术的四种最广泛批准的新冠肺炎初级疫苗在完全初级疫苗接种后用赛诺菲/GSK基于蛋白质的佐剂候选疫苗加强，以评估其安全性和免疫原性。</blockquote></p><p> Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p><p><blockquote>第一个队列（n=521）的参与者之前已经接种了授权的新冠肺炎mRNA疫苗（Moderna，辉瑞/BioNTech）或腺病毒载体疫苗（阿斯利康，强生）的批准给药方案。该初步分析包括试验参与者的数据，这些参与者在完成初级疫苗接种计划后4至10个月期间接受了一次5µg加强剂量的针对D614亲本病毒的佐剂重组蛋白疫苗。</blockquote></p><p> The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p><p><blockquote>该试验正在多个国家进行，包括美国、法国和英国。为了解决令人担忧的新冠肺炎变异体的出现，其他试验队列正在评估也含有β（B.1.351）变异体的单价和二价疫苗制剂的加强潜力。该试验的更多数据预计将在2022年上半年公布。奥密克戎变种在试验期间没有传播。使用加强试验参与者的血清，正在进行测试，以确定候选疫苗交叉中和奥密克戎病毒的能力。</blockquote></p><p> <b>About the Phase 3 efficacy trial (VAT0008)</b></p><p><blockquote><b>关于3期疗效试验（VAT0008）</b></blockquote></p><p></p><p> The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p><p><blockquote>这项正在进行的3期、随机、双盲、安慰剂对照试验的主要终点是在新型冠状病毒初治成人中预防有症状的COVID-19，次要终点是预防严重的COVID-19疾病和感染。该试验的第一阶段正在评估含有刺突蛋白的疫苗制剂对原始D614（亲代）病毒的功效，超过10,000名年龄&gt;18岁的参与者随机接受两剂10µg疫苗或安慰剂在美国、亚洲、非洲和拉丁美洲的研究中心第1天和第22天。试验的第二阶段是评估第二种二价制剂，添加B.1.351（β）变体的刺突蛋白。</blockquote></p><p> These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p><p><blockquote>这些努力得到了生物医学高级研究与发展局的联邦资金的支持，该局是美国负责准备和响应的助理部长办公室的一部分。卫生与公众服务部与美国合作。国防部化学、生物、辐射和核防御联合计划执行办公室，合同号为W15QKN-16-9-1002。</blockquote></p><p> <b>About the Sanofi and GSK collaboration</b></p><p><blockquote><b>关于赛诺菲与葛兰素史克合作</b></blockquote></p><p> In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p><p><blockquote>在两家公司的合作中，赛诺菲提供其重组抗原，葛兰素史克提供其大流行佐剂，这两个已建立的疫苗平台已被证明在对抗流感方面是成功的。</blockquote></p><p> <b>About GSK</b></p><p><blockquote><b>关于GSK</b></blockquote></p><p> GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p><p><blockquote>葛兰素史克是一家以科学为主导的全球医疗保健公司，有着特殊的目标：帮助人们做得更多，感觉更好，活得更长。葛兰素史克是全球领先的疫苗制造商。</blockquote></p><p> <b>About Sanofi</b></p><p><blockquote><b>关于赛诺菲</b></blockquote></p><p> Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p><p><blockquote>赛诺菲致力于支持人们应对健康挑战。是一家专注于人类健康的全球性生物制药公司。它通过疫苗预防疾病，提供创新的治疗方法来对抗疼痛和减轻痛苦。它支持少数患有罕见疾病的人和数百万患有长期慢性病的人。</blockquote></p><p> With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p><p><blockquote>赛诺菲在100个国家拥有超过100,000名员工，正在将科学创新转化为全球医疗保健解决方案。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation<blockquote>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation<blockquote>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-15 15:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p><p><blockquote><b>赛诺菲和葛兰素史克宣布其COVID-19候选疫苗的积极初步加强数据，并根据独立监测委员会的建议继续进行3期试验</b></blockquote></p><p> <ul>  <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>  <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>  <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li> </ul> Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p><p><blockquote><ul><li>阳性加强剂数据显示，接受的所有初级疫苗（mRNA或腺病毒）中的中和抗体增加了9至43倍，并且对于所有测试的年龄组，具有良好的安全性和耐受性</li><li>随着世界各地的人群越来越多地暴露于新冠肺炎变种，3期试验继续增加分析所需的事件数量；预计2022年第一季度业绩</li><li>公司打算在第三阶段结果公布后向监管机构提交加强数据</li></ul>赛诺菲和葛兰素史克今天宣布，他们的重组佐剂新冠肺炎候选疫苗的单次加强剂量产生了持续强烈的免疫反应。调查加强剂安全性和免疫原性的VAT0002临床试验的初步结果显示，无论接受的初级疫苗（阿斯利康、强生、Moderna、辉瑞/BioNTech）和所有测试年龄组，中和抗体都增加了9至43倍。加强剂耐受性良好，安全性与目前批准的新冠肺炎疫苗相似。这是迄今为止最全面的加强试验，旨在探索用于初级疫苗接种的不同疫苗技术的加强。</blockquote></p><p> The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p><p><blockquote>正在进行的全球3期试验VAT0008包括独立数据安全监测委员会(DSMB)的定期审查。在上次审查中，DSMB没有发现任何安全问题，并建议试验继续到2022年初，以积累更多数据。</blockquote></p><p> Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p><p><blockquote>监管机构要求在“幼稚”人群中证明3期疗效，即从未感染过新冠肺炎病毒（血清阴性）的参与者。3期试验在2021年第三季度招募了大多数参与者，恰逢德尔塔变异毒株导致全球感染COVID-19病毒的人数大幅增加。为了向监管机构提供加强疫苗提交所需的数据，该试验将继续累积分析所需的事件数量，预计将于2022年第一季度得出结果。</blockquote></p><p> <i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p><p><blockquote><i>“这些初步数据表明，无论您接种的是什么初级疫苗，我们都有一种强大的加强候选疫苗。”</i>赛诺菲巴斯德执行副总裁Thomas Triomphe说道。<i>“这与我们为不断变化的公共卫生需求提供相关响应的努力是一致的。虽然在快速变化的大流行环境中进行3期试验是一项挑战，但我们期待看到结果，以支持尽快提交我们的加强疫苗。”</i></blockquote></p><p> Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p><p><blockquote>葛兰素史克疫苗总裁罗杰·康纳补充道<i>：“随着大流行威胁的持续，目前占主导地位的德尔塔变异毒株和奥密克戎迅速取得进展，随着时间的推移，将继续需要加强疫苗来帮助保护人们。最初的加强数据很有希望，我们正在等待III期结果，以确定提供基于蛋白质的佐剂COVID-19疫苗的下一步措施。”</i></blockquote></p><p> In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p><p><blockquote>与此同时，赛诺菲继续为全球公共卫生需求做出贡献，生产了多达5亿剂BioNTech/辉瑞、Moderna和强生疫苗。</blockquote></p><p> <b>About the booster trial (VAT0002)</b></p><p><blockquote><b>关于加强试验（VAT0002）</b></blockquote></p><p> The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p><p><blockquote>VAT0002扩展试验是迄今为止进行的最全面的异源加强试验。在该试验的第一个队列中，使用mRNA和腺病毒载体技术的四种最广泛批准的新冠肺炎初级疫苗在完全初级疫苗接种后用赛诺菲/GSK基于蛋白质的佐剂候选疫苗加强，以评估其安全性和免疫原性。</blockquote></p><p> Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p><p><blockquote>第一个队列（n=521）的参与者之前已经接种了授权的新冠肺炎mRNA疫苗（Moderna，辉瑞/BioNTech）或腺病毒载体疫苗（阿斯利康，强生）的批准给药方案。该初步分析包括试验参与者的数据，这些参与者在完成初级疫苗接种计划后4至10个月期间接受了一次5µg加强剂量的针对D614亲本病毒的佐剂重组蛋白疫苗。</blockquote></p><p> The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p><p><blockquote>该试验正在多个国家进行，包括美国、法国和英国。为了解决令人担忧的新冠肺炎变异体的出现，其他试验队列正在评估也含有β（B.1.351）变异体的单价和二价疫苗制剂的加强潜力。该试验的更多数据预计将在2022年上半年公布。奥密克戎变种在试验期间没有传播。使用加强试验参与者的血清，正在进行测试，以确定候选疫苗交叉中和奥密克戎病毒的能力。</blockquote></p><p> <b>About the Phase 3 efficacy trial (VAT0008)</b></p><p><blockquote><b>关于3期疗效试验（VAT0008）</b></blockquote></p><p></p><p> The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p><p><blockquote>这项正在进行的3期、随机、双盲、安慰剂对照试验的主要终点是在新型冠状病毒初治成人中预防有症状的COVID-19，次要终点是预防严重的COVID-19疾病和感染。该试验的第一阶段正在评估含有刺突蛋白的疫苗制剂对原始D614（亲代）病毒的功效，超过10,000名年龄&gt;18岁的参与者随机接受两剂10µg疫苗或安慰剂在美国、亚洲、非洲和拉丁美洲的研究中心第1天和第22天。试验的第二阶段是评估第二种二价制剂，添加B.1.351（β）变体的刺突蛋白。</blockquote></p><p> These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p><p><blockquote>这些努力得到了生物医学高级研究与发展局的联邦资金的支持，该局是美国负责准备和响应的助理部长办公室的一部分。卫生与公众服务部与美国合作。国防部化学、生物、辐射和核防御联合计划执行办公室，合同号为W15QKN-16-9-1002。</blockquote></p><p> <b>About the Sanofi and GSK collaboration</b></p><p><blockquote><b>关于赛诺菲与葛兰素史克合作</b></blockquote></p><p> In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p><p><blockquote>在两家公司的合作中，赛诺菲提供其重组抗原，葛兰素史克提供其大流行佐剂，这两个已建立的疫苗平台已被证明在对抗流感方面是成功的。</blockquote></p><p> <b>About GSK</b></p><p><blockquote><b>关于GSK</b></blockquote></p><p> GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p><p><blockquote>葛兰素史克是一家以科学为主导的全球医疗保健公司，有着特殊的目标：帮助人们做得更多，感觉更好，活得更长。葛兰素史克是全球领先的疫苗制造商。</blockquote></p><p> <b>About Sanofi</b></p><p><blockquote><b>关于赛诺菲</b></blockquote></p><p> Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p><p><blockquote>赛诺菲致力于支持人们应对健康挑战。是一家专注于人类健康的全球性生物制药公司。它通过疫苗预防疾病，提供创新的治疗方法来对抗疼痛和减轻痛苦。它支持少数患有罕见疾病的人和数百万患有长期慢性病的人。</blockquote></p><p> With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p><p><blockquote>赛诺菲在100个国家拥有超过100,000名员工，正在将科学创新转化为全球医疗保健解决方案。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSK":"葛兰素史克","SNY":"赛诺菲安万特"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107549050","content_text":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation\n\nPositive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile\nPhase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022\nCompanies intend to file booster data with regulatory authorities following the Phase 3 results\n\nSanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.\nThe ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.\nRegulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.\n“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”\nRoger Connor, President of GSK Vaccines, added: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"\nIn parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson & Johnson vaccines.\nAbout the booster trial (VAT0002)\nThe VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.\nParticipants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson & Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.\nThe trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.\nAbout the Phase 3 efficacy trial (VAT0008)\nThe primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants >18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.\nThese efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.\nAbout the Sanofi and GSK collaboration\nIn the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.\nAbout GSK\nGSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.\nAbout Sanofi\nSanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.\nWith more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.","news_type":1,"symbols_score_info":{"SNY":0.9,"GSK":0.9}},"isVote":1,"tweetType":1,"viewCount":2387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862846916,"gmtCreate":1632872202664,"gmtModify":1632872202721,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862846916","repostId":"1106892312","repostType":4,"repost":{"id":"1106892312","kind":"news","pubTimestamp":1632870830,"share":"https://www.laohu8.com/m/news/1106892312?lang=zh_CN&edition=full","pubTime":"2021-09-29 07:13","market":"us","language":"en","title":"These high-flying stocks of 2021 dropped the most on Tuesday<blockquote>这些2021年飞涨的股票周二跌幅最大</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1106892312","media":"marketwatch","summary":"Stocks hit especially hard include Moderna, Nvidia and Google holding company Alphabet.\n\nThe Federal","content":"<p>  <b>Stocks hit especially hard include Moderna, Nvidia and Google holding company Alphabet.</b>  The Federal Reserve’s signaled policy change is having a predictable effect — pushing stock prices lower as bond yields become more attractive.</p><p><blockquote><b>受打击尤其严重的股票包括Moderna、英伟达和谷歌控股公司Alphabet。</b>美联储发出的政策变化信号正在产生可预见的影响——随着债券收益率变得更具吸引力，推动股价走低。</blockquote></p><p> This reverses some very strong action for U.S. stocks — at least for a day. Below is a list of 10 stocks that had increased at least 50% for 2021 through Sept. 27, but were pulled back the most on Sept. 28.</p><p><blockquote>这扭转了美国股市的一些非常强劲的走势——至少在一天内是这样。以下列出了截至9月27日2021年涨幅至少50%但在9月28日回调幅度最大的10只股票。</blockquote></p><p> The Dow Jones Industrial AverageDJIAdeclined 1.6%, while the S&amp;P 500 IndexSPXfell 2%. The Nasdaq Composite IndexCOMPfared worst, tumbling 2.8%.</p><p><blockquote>道琼斯工业平均指数DJIA下跌1.6%，标普500指数SPX下跌2%。纳斯达克综合指数表现最差，下跌2.8%。</blockquote></p><p> The yield on 10-year U.S. Treasury notesBX:TMUBMUSD10Yincreased by 5 basis points to 1.55%. That was up from 1.33% only a week earlier.</p><p><blockquote>10年期美国国债收益率BX：TMUBMUSD10Y上涨5个基点至1.55%。这一比例仅高于一周前的1.33%。</blockquote></p><p> Combined, there are 523 stocks in the S&amp;P 500 and Nasdaq-100NDXindexes. Among these stocks, 50 had risen at least 50% so far in 2021 through Sept. 27, excluding dividends, according to data provided by FactSet. Here are the 10 that declined the most on Sept. 28 — actually 11 stocks, as two common-share classes of Alphabet Inc.GOOGLGOOGare included:</p><p><blockquote>标普500和纳斯达克-100NDXindex总共有523只股票。FactSet提供的数据显示，截至9月27日，其中50只股票在2021年迄今已上涨至少50%（不包括股息）。以下是9月28日跌幅最大的10只股票——实际上是11只股票，其中包括Alphabet公司的两个普通股类别：</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3e62aed3304cd811cf41ce390e38c41c\" tg-width=\"1106\" tg-height=\"713\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/83133c4cfdb3554d40f750a60c91892c\" tg-width=\"1101\" tg-height=\"291\" width=\"100%\" height=\"auto\">Click the tickers for more about each company. Clickhere&nbsp;for Tomi Kilgore’s detailed guide to the wealth of information available for free on the quote page.</p><p><blockquote>单击股票代码了解有关每家公司的更多信息。点击此处获取孙铁麟·基尔戈的详细指南，了解报价页面上免费提供的大量信息。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These high-flying stocks of 2021 dropped the most on Tuesday<blockquote>这些2021年飞涨的股票周二跌幅最大</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese high-flying stocks of 2021 dropped the most on Tuesday<blockquote>这些2021年飞涨的股票周二跌幅最大</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">marketwatch</strong><span class=\"h-time small\">2021-09-29 07:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  <b>Stocks hit especially hard include Moderna, Nvidia and Google holding company Alphabet.</b>  The Federal Reserve’s signaled policy change is having a predictable effect — pushing stock prices lower as bond yields become more attractive.</p><p><blockquote><b>受打击尤其严重的股票包括Moderna、英伟达和谷歌控股公司Alphabet。</b>美联储发出的政策变化信号正在产生可预见的影响——随着债券收益率变得更具吸引力，推动股价走低。</blockquote></p><p> This reverses some very strong action for U.S. stocks — at least for a day. Below is a list of 10 stocks that had increased at least 50% for 2021 through Sept. 27, but were pulled back the most on Sept. 28.</p><p><blockquote>这扭转了美国股市的一些非常强劲的走势——至少在一天内是这样。以下列出了截至9月27日2021年涨幅至少50%但在9月28日回调幅度最大的10只股票。</blockquote></p><p> The Dow Jones Industrial AverageDJIAdeclined 1.6%, while the S&amp;P 500 IndexSPXfell 2%. The Nasdaq Composite IndexCOMPfared worst, tumbling 2.8%.</p><p><blockquote>道琼斯工业平均指数DJIA下跌1.6%，标普500指数SPX下跌2%。纳斯达克综合指数表现最差，下跌2.8%。</blockquote></p><p> The yield on 10-year U.S. Treasury notesBX:TMUBMUSD10Yincreased by 5 basis points to 1.55%. That was up from 1.33% only a week earlier.</p><p><blockquote>10年期美国国债收益率BX：TMUBMUSD10Y上涨5个基点至1.55%。这一比例仅高于一周前的1.33%。</blockquote></p><p> Combined, there are 523 stocks in the S&amp;P 500 and Nasdaq-100NDXindexes. Among these stocks, 50 had risen at least 50% so far in 2021 through Sept. 27, excluding dividends, according to data provided by FactSet. Here are the 10 that declined the most on Sept. 28 — actually 11 stocks, as two common-share classes of Alphabet Inc.GOOGLGOOGare included:</p><p><blockquote>标普500和纳斯达克-100NDXindex总共有523只股票。FactSet提供的数据显示，截至9月27日，其中50只股票在2021年迄今已上涨至少50%（不包括股息）。以下是9月28日跌幅最大的10只股票——实际上是11只股票，其中包括Alphabet公司的两个普通股类别：</blockquote></p><p> <img src=\"https://static.tigerbbs.com/3e62aed3304cd811cf41ce390e38c41c\" tg-width=\"1106\" tg-height=\"713\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/83133c4cfdb3554d40f750a60c91892c\" tg-width=\"1101\" tg-height=\"291\" width=\"100%\" height=\"auto\">Click the tickers for more about each company. Clickhere&nbsp;for Tomi Kilgore’s detailed guide to the wealth of information available for free on the quote page.</p><p><blockquote>单击股票代码了解有关每家公司的更多信息。点击此处获取孙铁麟·基尔戈的详细指南，了解报价页面上免费提供的大量信息。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/these-high-flying-stocks-of-2021-have-dropped-the-most-today-11632846406?mod=home-page\">marketwatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/these-high-flying-stocks-of-2021-have-dropped-the-most-today-11632846406?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106892312","content_text":"Stocks hit especially hard include Moderna, Nvidia and Google holding company Alphabet.\n\nThe Federal Reserve’s signaled policy change is having a predictable effect — pushing stock prices lower as bond yields become more attractive.\nThis reverses some very strong action for U.S. stocks — at least for a day. Below is a list of 10 stocks that had increased at least 50% for 2021 through Sept. 27, but were pulled back the most on Sept. 28.\nThe Dow Jones Industrial AverageDJIAdeclined 1.6%, while the S&P 500 IndexSPXfell 2%. The Nasdaq Composite IndexCOMPfared worst, tumbling 2.8%.\nThe yield on 10-year U.S. Treasury notesBX:TMUBMUSD10Yincreased by 5 basis points to 1.55%. That was up from 1.33% only a week earlier.\nCombined, there are 523 stocks in the S&P 500 and Nasdaq-100NDXindexes. Among these stocks, 50 had risen at least 50% so far in 2021 through Sept. 27, excluding dividends, according to data provided by FactSet. Here are the 10 that declined the most on Sept. 28 — actually 11 stocks, as two common-share classes of Alphabet Inc.GOOGLGOOGare included:\nClick the tickers for more about each company. Clickhere for Tomi Kilgore’s detailed guide to the wealth of information available for free on the quote page.","news_type":1,"symbols_score_info":{"SPY":0.9,".IXIC":0.9,".SPX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":818811973,"gmtCreate":1630394573592,"gmtModify":1704959622496,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/818811973","repostId":"2163833181","repostType":4,"isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832945666,"gmtCreate":1629580972555,"gmtModify":1631893111820,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/832945666","repostId":"1107075259","repostType":4,"repost":{"id":"1107075259","kind":"news","pubTimestamp":1629509852,"share":"https://www.laohu8.com/m/news/1107075259?lang=zh_CN&edition=full","pubTime":"2021-08-21 09:37","market":"us","language":"en","title":"Ignore Elon Musk’s dancing distraction and face the dangers ahead for Tesla<blockquote>忽略Elon Musk跳舞的干扰，面对特斯拉未来的危险</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107075259","media":"MarketWatch","summary":"Investigations into automated-driving systems and the statements made about it by the electric-car company and its chief executive deserve more attention than their latest fanciful technology aspirations and timelines.$Investors$ should ignore Elon Musk’s latest dance and focus instead on the growing issues Tesla is facing because of its chief executive’s exaggerated claims about his company’s technological capabilities.At $Tesla Motors$’s AI Day late Thursday, self-named Technoking Musk said th","content":"<p>  <b>Investigations into automated-driving systems and the statements made about it by the electric-car company and its chief executive deserve more attention than their latest fanciful technology aspirations and timelines.</b>  <a href=\"https://laohu8.com/S/ISBC\">Investors</a> should ignore Elon Musk’s latest dance and focus instead on the growing issues Tesla is facing because of its chief executive’s exaggerated claims about his company’s technological capabilities.</p><p><blockquote><b>对自动驾驶系统的调查以及这家电动汽车公司及其首席执行官就此发表的声明比他们最新的异想天开的技术愿望和时间表更值得关注。</b><a href=\"https://laohu8.com/S/ISBC\">投资者</a>应该忽略Elon Musk的最新舞蹈，而是关注特斯拉因首席执行官夸大其公司技术能力而面临的日益严重的问题。</blockquote></p><p> At <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a>’s&nbsp;AI Day late Thursday, self-named Technoking Musk said that the company is working on a humanoid robot as “Tesla is arguably the world’s biggest robotics company because our cars are like semi-sentient robots on wheels.”</p><p><blockquote>在<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>周四晚些时候，自称Technoking Musk的马斯克表示，该公司正在开发一款人形机器人，因为“特斯拉可以说是世界上最大的机器人公司，因为我们的汽车就像轮子上的半感知机器人。”</blockquote></p><p> After a white-suited human did a brief dance for the believers in the audience and on a livestream, Musk came on the stage and showed only computer-generated images of a 5’8″ humanoid robot thathe claimed Tesla will produce a prototype of sometime next year. He inferred it could be used for manufacturing or boring repetitive tasks, like grocery shopping and will have a full self-driving computer.</p><p><blockquote>在一名身穿白色西装的人类为观众和直播中的信徒跳了一支简短的舞蹈后，马斯克走上舞台，只展示了一个5英尺8英寸的人形机器人的计算机生成图像，马斯克声称特斯拉将在明年的某个时候生产出一个原型。他推断它可以用于制造或无聊的重复性任务，例如杂货店购物，并且将配备全自动驾驶计算机。</blockquote></p><p> As always with Musk and Tesla, the timeline is highly doubtful to anyone with basic knowledge of the technology in question. Fortunately, the antics did not fool everyone on Wall Street, some of whom may be getting tired of his shenanigans.</p><p><blockquote>和马斯克和特斯拉一样，对于任何对相关技术有基本了解的人来说，时间表都是非常值得怀疑的。幸运的是，这些滑稽动作并没有愚弄华尔街的所有人，其中一些人可能已经厌倦了他的恶作剧。</blockquote></p><p> “Unfortunately, as we have seen with robotaxis and other future sci-fi projects for Musk, we view this&nbsp;Tesla&nbsp;Bot as an absolute head scratcher that will further agitate investors at a time the Street is showing growing concern around rising EV competition and safety issues for&nbsp;Tesla,” said Dan Ives, a Wedbush Securities analyst, in a note to clients early Friday.</p><p><blockquote>“不幸的是，正如我们在机器人出租车和马斯克未来的其他科幻项目中所看到的那样，我们认为这款特斯拉机器人绝对令人挠头，在华尔街对电动汽车竞争和安全日益担忧之际，它将进一步激怒投资者。特斯拉的问题，”韦德布什证券分析师Dan Ives在周五早些时候给客户的一份报告中表示。</blockquote></p><p> The safety issues Ives mentions are what investors should be attuned to right now, because it appears the government is finally stepping up and taking note of a problem this column has long pointed out: Musk repeatedly oversells the current and near-term potential for his automotive autonomy advanced technology.</p><p><blockquote>艾夫斯提到的安全问题是投资者现在应该关注的问题，因为政府似乎终于站出来并注意到本专栏长期以来指出的一个问题：马斯克一再高估其汽车自动驾驶先进技术的当前和近期潜力。</blockquote></p><p> <a href=\"https://laohu8.com/S/JE\">Just</a> a day before Thursday’s “AI Day” spectacle,two U.S. senators asked the Federal Trade Commission to investigate both Tesla’s and Musk’s “repeated overstatements of their vehicles’ capabilities”in regards to the marketing of Tesla’s “Full Self Driving” product. Tesla charges thousands of dollars at purchase (or as little as $100 a month) for software that is nowhere near full self-driving, a practice that has already led toa recent review by California Department of Motor Vehiclesanda German ruling that Tesla could not market the product as such.</p><p><blockquote><a href=\"https://laohu8.com/S/JE\">刚刚</a>在周四“人工智能日”奇观的前一天，两名美国参议员要求联邦贸易委员会调查特斯拉和马斯克在特斯拉“全自动驾驶”产品营销方面“一再夸大其车辆功能”的行为。特斯拉对远未完全自动驾驶的软件在购买时收取数千美元（或每月低至100美元）的费用，这种做法已经导致加州机动车辆管理局最近进行审查，德国裁定特斯拉不能销售该产品本身。</blockquote></p><p> “Language matters,” said Selika Talbott, a professorial lecturer in the department of public administration and policy at <a href=\"https://laohu8.com/S/AFG\">American</a> University in <a href=\"https://laohu8.com/S/WASH\">Washington</a> DC. “The use of this terminology is false and misleading and unsafe for the general public. The notions of assisted driving and autonomous vehicles and their differences are not fully understood by the general public.”</p><p><blockquote>“语言很重要，”塞利卡·塔尔博特(Selika Talbott)说。<a href=\"https://laohu8.com/S/AFG\">美国的</a>大学在<a href=\"https://laohu8.com/S/WASH\">华盛顿州</a>直流电。“这个术语的使用是错误的、误导性的，对公众来说是不安全的。辅助驾驶和自动驾驶汽车的概念及其区别并没有被公众完全理解。”</blockquote></p><p> “Tesla has highly assisted technology in their vehicle, but at no point should anyone behind the wheel think that vehicle can drive itself, because it can’t,” Talbott said.</p><p><blockquote>塔尔博特说：“特斯拉在他们的车辆中配备了高度辅助技术，但任何驾驶人员都不应该认为车辆可以自动驾驶，因为它不能。”</blockquote></p><p> The week began with news of a federal investigation into Tesla’s Autopilot system after cars using the feature crashed into stopped emergency vehicles.The <a href=\"https://laohu8.com/S/NHLD\">National</a> <a href=\"https://laohu8.com/S/HIHO\">Highway</a> Traffic Safety Administration is looking into a series of crashesby Tesla cars that had the advanced driver-assistance system enabled. NHTSA said that itopened an inquiry into 11 Tesla crashesthat involved emergency vehicles, while still investigating a series of collisions involving cars enabled with <a href=\"https://laohu8.com/S/AEIS\">Advanced</a> Driver Assistance Systems (ADAS) and tractor-trailers.</p><p><blockquote>本周伊始，有消息称，使用该功能的汽车撞上了停下来的紧急车辆，联邦政府对特斯拉的自动驾驶系统进行了调查。<a href=\"https://laohu8.com/S/NHLD\">国家的</a><a href=\"https://laohu8.com/S/HIHO\">公路</a>交通安全管理局正在调查一系列启用了高级驾驶员辅助系统的特斯拉汽车发生的撞车事故。NHTSA表示，已对11起涉及紧急车辆的特斯拉事故展开调查，同时仍在调查一系列涉及启用紧急车辆的汽车的碰撞事故<a href=\"https://laohu8.com/S/AEIS\">先进的</a>驾驶员辅助系统（ADAS）和牵引车拖车。</blockquote></p><p> The latest outcry on Capitol <a href=\"https://laohu8.com/S/HIL\">Hill</a> follows a stream of news reports and/or social media posts and YouTube videos of drivers engaging in extremely risky behavior while testing the so-called self-driving features of their Tesla. In May, Steven Michael Hendrickson,a 35-year-old father of two in Fontana, Calif., died when his Tesla hit an overturned semitruck. Earlier he had posted videos of driving without his hands on the wheel of his car on the freeway, but the NHTSA was still investigating the role of Autopilot in the crash.</p><p><blockquote>国会大厦的最新抗议<a href=\"https://laohu8.com/S/HIL\">山丘</a>关注一系列新闻报道和/或社交媒体帖子和YouTube视频，这些视频显示司机在测试特斯拉的所谓自动驾驶功能时做出了极其危险的行为。今年5月，加利福尼亚州丰塔纳市35岁的两个孩子的父亲Steven Michael Hendrickson在他的特斯拉撞上一辆翻倒的半挂卡车时死亡。早些时候，他发布了在高速公路上双手不放在方向盘上驾驶的视频，但NHTSA仍在调查自动驾驶仪在事故中的作用。</blockquote></p><p> “The vehicles that Tesla is producing are driver-assisted systems,” said Bryan Reimer, a research scientist at the MIT Center for Transportation and Logistics. “They are assisting the driver, and the driver needs to maintain vigilance.”</p><p><blockquote>“特斯拉正在生产的车辆是驾驶辅助系统，”麻省理工学院运输和物流中心的研究科学家布莱恩·赖默说。“他们在协助司机，司机需要保持警惕。”</blockquote></p><p></p><p> It is important to note the difference between Tesla’s dual products with misleading names. “Autopilot” is an ADAS system, a highly advanced version of cruise control meant for highway driving that enables “your car to steer, accelerate and brake automatically within its lane under your active supervision, assisting with the most burdensome parts of driving,” according to Tesla’s website. Tesla also offers the “FSD” package, now available by a subscription of $99 to $199 a month, which it describes as “access to a suite of more advanced driver assistance features, designed to provide more active guidance and assisted driving under your active supervision.”</p><p><blockquote>值得注意的是，特斯拉具有误导性名称的双产品之间的差异。“Autopilot”是一种ADAS系统，是一种高度先进的巡航控制版本，适用于高速公路驾驶，使“您的汽车能够在您的主动监督下在车道内自动转向、加速和制动，协助驾驶中最繁重的部分”。特斯拉的网站。特斯拉还提供“FSD”套餐，现在每月订阅费用为99至199美元，其将其描述为“访问一套更先进的驾驶员辅助功能，旨在在您的主动监督下提供更主动的指导和辅助驾驶。”</blockquote></p><p> If only Musk described these systems in a similar manner to the official website. In analyst conference calls and in Tesla’s multi-hour long presentations to its fan base, Musk has been proclaiming that with this software, full autonomy is around the corner.</p><p><blockquote>要是马斯克用和官网类似的方式描述这些系统就好了。在评级分析师会议上以及特斯拉向其粉丝群进行的长达数小时的演示中，马斯克一直宣称，有了这款软件，完全自主指日可待。</blockquote></p><p> “We&nbsp;basically&nbsp;have&nbsp;to&nbsp;solve&nbsp;real-world vision AI and we are,” he said in an earnings call in April. “And the key to solving this is also having some massive data set. So just having well over <a href=\"https://laohu8.com/S/AONE.U\">one</a> million cars on the road that are collecting data… But I am highly confident that we&nbsp;will&nbsp;get&nbsp;this&nbsp;done.”</p><p><blockquote>“我们基本上必须解决现实世界的视觉人工智能，我们确实做到了，”他在4月份的财报看涨期权上表示。“解决这个问题的关键还在于拥有一些大规模的数据集。所以只要有足够的数据集<a href=\"https://laohu8.com/S/AONE.U\">一</a>道路上有数百万辆汽车正在收集数据……但我非常有信心我们能够完成这项工作。”</blockquote></p><p> But for all of Musk’s bluster and huge fan base, investors are starting to note that the company’s tactics involving full self-driving technology are dangerous, as opposed to the other companies that are testing autonomous vehicles.</p><p><blockquote>但尽管马斯克夸夸其谈，拥有庞大的粉丝群，但投资者开始注意到，与其他正在测试自动驾驶汽车的公司相比，该公司涉及全自动驾驶技术的策略是危险的。</blockquote></p><p> For example, <a href=\"https://laohu8.com/S/GOOG\">Alphabet</a> Inc.’sGOOGGOOGLWaymo, the company with the most hours of autonomous vehicle driving, is currently operating a small scale robotaxi service in parts of Arizona around Phoenix that are not densely populated, without human drivers. It is the only one of its kind in the U.S. In California, Waymo has permits from the DMV to conduct AV testing with a human driver behind the wheel.</p><p><blockquote>例如，<a href=\"https://laohu8.com/S/GOOG\">Alphabet</a>Inc.旗下的GOOGGOOGLWaymo是自动驾驶汽车时间最长的公司，目前正在亚利桑那州凤凰城周围人口不稠密的地区运营小规模机器人出租车服务，没有人类司机。这是美国唯一一家此类公司。在加利福尼亚州，Waymo获得了DMV的许可，可以在人类驾驶员驾驶的情况下进行AV测试。</blockquote></p><p> “Waymo cannot just start selling their AVs to anyone, and they can’t just drive them on the roadway, our regulatory system does not allow for that,” Talbott of <a href=\"https://laohu8.com/S/AMSWA\">American</a> University said. “You can test them but no publicly available self-driving car is on the market for purchase because it doesn’t exist.”</p><p><blockquote>“Waymo不能开始向任何人出售他们的自动驾驶汽车，他们也不能只是在道路上驾驶它们，我们的监管体系不允许这样做，”<a href=\"https://laohu8.com/S/AMSWA\">美国的</a>大学表示。“你可以测试它们，但市场上没有公开的自动驾驶汽车可供购买，因为它不存在。”</blockquote></p><p> With FSD testing being done in the real world with untrained drivers, Tesla is conducting the equivalent of clinical trials of a new drug without any professional hourly or daily monitoring of the patient.</p><p><blockquote>随着FSD测试在现实世界中由未经训练的驾驶员进行，特斯拉正在进行相当于新药临床试验的试验，而无需对患者进行任何专业的每小时或每天监测。</blockquote></p><p> “They are calling it beta, it is a beta system, they are exposing people to substantive risk,” Reimer said.</p><p><blockquote>“他们称之为测试版，这是一个测试版系统，他们让人们面临重大风险，”赖默说。</blockquote></p><p> Musk’s latest bot is yet another distraction, much like the flame thrower in 2018 sold by his Boring Company, his unwanted assistance to try and help the boys stuck in a cave in Thailand, and other projects. Investors should not let these distractions get in the way of the real issues that Musk seems to be refusing to acknowledge as he continues to oversell his company’s technological abilities.</p><p><blockquote>马斯克的最新机器人是另一个干扰，就像他的Boring Company在2018年出售的火焰喷射器、他试图帮助被困在泰国洞穴中的男孩的不必要的帮助以及其他项目一样。投资者不应该让这些干扰妨碍马斯克似乎拒绝承认的真正问题，因为他继续夸大公司的技术能力。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ignore Elon Musk’s dancing distraction and face the dangers ahead for Tesla<blockquote>忽略Elon Musk跳舞的干扰，面对特斯拉未来的危险</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIgnore Elon Musk’s dancing distraction and face the dangers ahead for Tesla<blockquote>忽略Elon Musk跳舞的干扰，面对特斯拉未来的危险</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-08-21 09:37</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  <b>Investigations into automated-driving systems and the statements made about it by the electric-car company and its chief executive deserve more attention than their latest fanciful technology aspirations and timelines.</b>  <a href=\"https://laohu8.com/S/ISBC\">Investors</a> should ignore Elon Musk’s latest dance and focus instead on the growing issues Tesla is facing because of its chief executive’s exaggerated claims about his company’s technological capabilities.</p><p><blockquote><b>对自动驾驶系统的调查以及这家电动汽车公司及其首席执行官就此发表的声明比他们最新的异想天开的技术愿望和时间表更值得关注。</b><a href=\"https://laohu8.com/S/ISBC\">投资者</a>应该忽略Elon Musk的最新舞蹈，而是关注特斯拉因首席执行官夸大其公司技术能力而面临的日益严重的问题。</blockquote></p><p> At <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a>’s&nbsp;AI Day late Thursday, self-named Technoking Musk said that the company is working on a humanoid robot as “Tesla is arguably the world’s biggest robotics company because our cars are like semi-sentient robots on wheels.”</p><p><blockquote>在<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>周四晚些时候，自称Technoking Musk的马斯克表示，该公司正在开发一款人形机器人，因为“特斯拉可以说是世界上最大的机器人公司，因为我们的汽车就像轮子上的半感知机器人。”</blockquote></p><p> After a white-suited human did a brief dance for the believers in the audience and on a livestream, Musk came on the stage and showed only computer-generated images of a 5’8″ humanoid robot thathe claimed Tesla will produce a prototype of sometime next year. He inferred it could be used for manufacturing or boring repetitive tasks, like grocery shopping and will have a full self-driving computer.</p><p><blockquote>在一名身穿白色西装的人类为观众和直播中的信徒跳了一支简短的舞蹈后，马斯克走上舞台，只展示了一个5英尺8英寸的人形机器人的计算机生成图像，马斯克声称特斯拉将在明年的某个时候生产出一个原型。他推断它可以用于制造或无聊的重复性任务，例如杂货店购物，并且将配备全自动驾驶计算机。</blockquote></p><p> As always with Musk and Tesla, the timeline is highly doubtful to anyone with basic knowledge of the technology in question. Fortunately, the antics did not fool everyone on Wall Street, some of whom may be getting tired of his shenanigans.</p><p><blockquote>和马斯克和特斯拉一样，对于任何对相关技术有基本了解的人来说，时间表都是非常值得怀疑的。幸运的是，这些滑稽动作并没有愚弄华尔街的所有人，其中一些人可能已经厌倦了他的恶作剧。</blockquote></p><p> “Unfortunately, as we have seen with robotaxis and other future sci-fi projects for Musk, we view this&nbsp;Tesla&nbsp;Bot as an absolute head scratcher that will further agitate investors at a time the Street is showing growing concern around rising EV competition and safety issues for&nbsp;Tesla,” said Dan Ives, a Wedbush Securities analyst, in a note to clients early Friday.</p><p><blockquote>“不幸的是，正如我们在机器人出租车和马斯克未来的其他科幻项目中所看到的那样，我们认为这款特斯拉机器人绝对令人挠头，在华尔街对电动汽车竞争和安全日益担忧之际，它将进一步激怒投资者。特斯拉的问题，”韦德布什证券分析师Dan Ives在周五早些时候给客户的一份报告中表示。</blockquote></p><p> The safety issues Ives mentions are what investors should be attuned to right now, because it appears the government is finally stepping up and taking note of a problem this column has long pointed out: Musk repeatedly oversells the current and near-term potential for his automotive autonomy advanced technology.</p><p><blockquote>艾夫斯提到的安全问题是投资者现在应该关注的问题，因为政府似乎终于站出来并注意到本专栏长期以来指出的一个问题：马斯克一再高估其汽车自动驾驶先进技术的当前和近期潜力。</blockquote></p><p> <a href=\"https://laohu8.com/S/JE\">Just</a> a day before Thursday’s “AI Day” spectacle,two U.S. senators asked the Federal Trade Commission to investigate both Tesla’s and Musk’s “repeated overstatements of their vehicles’ capabilities”in regards to the marketing of Tesla’s “Full Self Driving” product. Tesla charges thousands of dollars at purchase (or as little as $100 a month) for software that is nowhere near full self-driving, a practice that has already led toa recent review by California Department of Motor Vehiclesanda German ruling that Tesla could not market the product as such.</p><p><blockquote><a href=\"https://laohu8.com/S/JE\">刚刚</a>在周四“人工智能日”奇观的前一天，两名美国参议员要求联邦贸易委员会调查特斯拉和马斯克在特斯拉“全自动驾驶”产品营销方面“一再夸大其车辆功能”的行为。特斯拉对远未完全自动驾驶的软件在购买时收取数千美元（或每月低至100美元）的费用，这种做法已经导致加州机动车辆管理局最近进行审查，德国裁定特斯拉不能销售该产品本身。</blockquote></p><p> “Language matters,” said Selika Talbott, a professorial lecturer in the department of public administration and policy at <a href=\"https://laohu8.com/S/AFG\">American</a> University in <a href=\"https://laohu8.com/S/WASH\">Washington</a> DC. “The use of this terminology is false and misleading and unsafe for the general public. The notions of assisted driving and autonomous vehicles and their differences are not fully understood by the general public.”</p><p><blockquote>“语言很重要，”塞利卡·塔尔博特(Selika Talbott)说。<a href=\"https://laohu8.com/S/AFG\">美国的</a>大学在<a href=\"https://laohu8.com/S/WASH\">华盛顿州</a>直流电。“这个术语的使用是错误的、误导性的，对公众来说是不安全的。辅助驾驶和自动驾驶汽车的概念及其区别并没有被公众完全理解。”</blockquote></p><p> “Tesla has highly assisted technology in their vehicle, but at no point should anyone behind the wheel think that vehicle can drive itself, because it can’t,” Talbott said.</p><p><blockquote>塔尔博特说：“特斯拉在他们的车辆中配备了高度辅助技术，但任何驾驶人员都不应该认为车辆可以自动驾驶，因为它不能。”</blockquote></p><p> The week began with news of a federal investigation into Tesla’s Autopilot system after cars using the feature crashed into stopped emergency vehicles.The <a href=\"https://laohu8.com/S/NHLD\">National</a> <a href=\"https://laohu8.com/S/HIHO\">Highway</a> Traffic Safety Administration is looking into a series of crashesby Tesla cars that had the advanced driver-assistance system enabled. NHTSA said that itopened an inquiry into 11 Tesla crashesthat involved emergency vehicles, while still investigating a series of collisions involving cars enabled with <a href=\"https://laohu8.com/S/AEIS\">Advanced</a> Driver Assistance Systems (ADAS) and tractor-trailers.</p><p><blockquote>本周伊始，有消息称，使用该功能的汽车撞上了停下来的紧急车辆，联邦政府对特斯拉的自动驾驶系统进行了调查。<a href=\"https://laohu8.com/S/NHLD\">国家的</a><a href=\"https://laohu8.com/S/HIHO\">公路</a>交通安全管理局正在调查一系列启用了高级驾驶员辅助系统的特斯拉汽车发生的撞车事故。NHTSA表示，已对11起涉及紧急车辆的特斯拉事故展开调查，同时仍在调查一系列涉及启用紧急车辆的汽车的碰撞事故<a href=\"https://laohu8.com/S/AEIS\">先进的</a>驾驶员辅助系统（ADAS）和牵引车拖车。</blockquote></p><p> The latest outcry on Capitol <a href=\"https://laohu8.com/S/HIL\">Hill</a> follows a stream of news reports and/or social media posts and YouTube videos of drivers engaging in extremely risky behavior while testing the so-called self-driving features of their Tesla. In May, Steven Michael Hendrickson,a 35-year-old father of two in Fontana, Calif., died when his Tesla hit an overturned semitruck. Earlier he had posted videos of driving without his hands on the wheel of his car on the freeway, but the NHTSA was still investigating the role of Autopilot in the crash.</p><p><blockquote>国会大厦的最新抗议<a href=\"https://laohu8.com/S/HIL\">山丘</a>关注一系列新闻报道和/或社交媒体帖子和YouTube视频，这些视频显示司机在测试特斯拉的所谓自动驾驶功能时做出了极其危险的行为。今年5月，加利福尼亚州丰塔纳市35岁的两个孩子的父亲Steven Michael Hendrickson在他的特斯拉撞上一辆翻倒的半挂卡车时死亡。早些时候，他发布了在高速公路上双手不放在方向盘上驾驶的视频，但NHTSA仍在调查自动驾驶仪在事故中的作用。</blockquote></p><p> “The vehicles that Tesla is producing are driver-assisted systems,” said Bryan Reimer, a research scientist at the MIT Center for Transportation and Logistics. “They are assisting the driver, and the driver needs to maintain vigilance.”</p><p><blockquote>“特斯拉正在生产的车辆是驾驶辅助系统，”麻省理工学院运输和物流中心的研究科学家布莱恩·赖默说。“他们在协助司机，司机需要保持警惕。”</blockquote></p><p></p><p> It is important to note the difference between Tesla’s dual products with misleading names. “Autopilot” is an ADAS system, a highly advanced version of cruise control meant for highway driving that enables “your car to steer, accelerate and brake automatically within its lane under your active supervision, assisting with the most burdensome parts of driving,” according to Tesla’s website. Tesla also offers the “FSD” package, now available by a subscription of $99 to $199 a month, which it describes as “access to a suite of more advanced driver assistance features, designed to provide more active guidance and assisted driving under your active supervision.”</p><p><blockquote>值得注意的是，特斯拉具有误导性名称的双产品之间的差异。“Autopilot”是一种ADAS系统，是一种高度先进的巡航控制版本，适用于高速公路驾驶，使“您的汽车能够在您的主动监督下在车道内自动转向、加速和制动，协助驾驶中最繁重的部分”。特斯拉的网站。特斯拉还提供“FSD”套餐，现在每月订阅费用为99至199美元，其将其描述为“访问一套更先进的驾驶员辅助功能，旨在在您的主动监督下提供更主动的指导和辅助驾驶。”</blockquote></p><p> If only Musk described these systems in a similar manner to the official website. In analyst conference calls and in Tesla’s multi-hour long presentations to its fan base, Musk has been proclaiming that with this software, full autonomy is around the corner.</p><p><blockquote>要是马斯克用和官网类似的方式描述这些系统就好了。在评级分析师会议上以及特斯拉向其粉丝群进行的长达数小时的演示中，马斯克一直宣称，有了这款软件，完全自主指日可待。</blockquote></p><p> “We&nbsp;basically&nbsp;have&nbsp;to&nbsp;solve&nbsp;real-world vision AI and we are,” he said in an earnings call in April. “And the key to solving this is also having some massive data set. So just having well over <a href=\"https://laohu8.com/S/AONE.U\">one</a> million cars on the road that are collecting data… But I am highly confident that we&nbsp;will&nbsp;get&nbsp;this&nbsp;done.”</p><p><blockquote>“我们基本上必须解决现实世界的视觉人工智能，我们确实做到了，”他在4月份的财报看涨期权上表示。“解决这个问题的关键还在于拥有一些大规模的数据集。所以只要有足够的数据集<a href=\"https://laohu8.com/S/AONE.U\">一</a>道路上有数百万辆汽车正在收集数据……但我非常有信心我们能够完成这项工作。”</blockquote></p><p> But for all of Musk’s bluster and huge fan base, investors are starting to note that the company’s tactics involving full self-driving technology are dangerous, as opposed to the other companies that are testing autonomous vehicles.</p><p><blockquote>但尽管马斯克夸夸其谈，拥有庞大的粉丝群，但投资者开始注意到，与其他正在测试自动驾驶汽车的公司相比，该公司涉及全自动驾驶技术的策略是危险的。</blockquote></p><p> For example, <a href=\"https://laohu8.com/S/GOOG\">Alphabet</a> Inc.’sGOOGGOOGLWaymo, the company with the most hours of autonomous vehicle driving, is currently operating a small scale robotaxi service in parts of Arizona around Phoenix that are not densely populated, without human drivers. It is the only one of its kind in the U.S. In California, Waymo has permits from the DMV to conduct AV testing with a human driver behind the wheel.</p><p><blockquote>例如，<a href=\"https://laohu8.com/S/GOOG\">Alphabet</a>Inc.旗下的GOOGGOOGLWaymo是自动驾驶汽车时间最长的公司，目前正在亚利桑那州凤凰城周围人口不稠密的地区运营小规模机器人出租车服务，没有人类司机。这是美国唯一一家此类公司。在加利福尼亚州，Waymo获得了DMV的许可，可以在人类驾驶员驾驶的情况下进行AV测试。</blockquote></p><p> “Waymo cannot just start selling their AVs to anyone, and they can’t just drive them on the roadway, our regulatory system does not allow for that,” Talbott of <a href=\"https://laohu8.com/S/AMSWA\">American</a> University said. “You can test them but no publicly available self-driving car is on the market for purchase because it doesn’t exist.”</p><p><blockquote>“Waymo不能开始向任何人出售他们的自动驾驶汽车，他们也不能只是在道路上驾驶它们，我们的监管体系不允许这样做，”<a href=\"https://laohu8.com/S/AMSWA\">美国的</a>大学表示。“你可以测试它们，但市场上没有公开的自动驾驶汽车可供购买，因为它不存在。”</blockquote></p><p> With FSD testing being done in the real world with untrained drivers, Tesla is conducting the equivalent of clinical trials of a new drug without any professional hourly or daily monitoring of the patient.</p><p><blockquote>随着FSD测试在现实世界中由未经训练的驾驶员进行，特斯拉正在进行相当于新药临床试验的试验，而无需对患者进行任何专业的每小时或每天监测。</blockquote></p><p> “They are calling it beta, it is a beta system, they are exposing people to substantive risk,” Reimer said.</p><p><blockquote>“他们称之为测试版，这是一个测试版系统，他们让人们面临重大风险，”赖默说。</blockquote></p><p> Musk’s latest bot is yet another distraction, much like the flame thrower in 2018 sold by his Boring Company, his unwanted assistance to try and help the boys stuck in a cave in Thailand, and other projects. Investors should not let these distractions get in the way of the real issues that Musk seems to be refusing to acknowledge as he continues to oversell his company’s technological abilities.</p><p><blockquote>马斯克的最新机器人是另一个干扰，就像他的Boring Company在2018年出售的火焰喷射器、他试图帮助被困在泰国洞穴中的男孩的不必要的帮助以及其他项目一样。投资者不应该让这些干扰妨碍马斯克似乎拒绝承认的真正问题，因为他继续夸大公司的技术能力。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/ignore-elon-musks-dancing-distraction-and-face-the-dangers-ahead-for-tesla-11629488276?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/story/ignore-elon-musks-dancing-distraction-and-face-the-dangers-ahead-for-tesla-11629488276?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1107075259","content_text":"Investigations into automated-driving systems and the statements made about it by the electric-car company and its chief executive deserve more attention than their latest fanciful technology aspirations and timelines.\n\nInvestors should ignore Elon Musk’s latest dance and focus instead on the growing issues Tesla is facing because of its chief executive’s exaggerated claims about his company’s technological capabilities.\nAt Tesla Motors’s AI Day late Thursday, self-named Technoking Musk said that the company is working on a humanoid robot as “Tesla is arguably the world’s biggest robotics company because our cars are like semi-sentient robots on wheels.”\nAfter a white-suited human did a brief dance for the believers in the audience and on a livestream, Musk came on the stage and showed only computer-generated images of a 5’8″ humanoid robot thathe claimed Tesla will produce a prototype of sometime next year. He inferred it could be used for manufacturing or boring repetitive tasks, like grocery shopping and will have a full self-driving computer.\nAs always with Musk and Tesla, the timeline is highly doubtful to anyone with basic knowledge of the technology in question. Fortunately, the antics did not fool everyone on Wall Street, some of whom may be getting tired of his shenanigans.\n“Unfortunately, as we have seen with robotaxis and other future sci-fi projects for Musk, we view this Tesla Bot as an absolute head scratcher that will further agitate investors at a time the Street is showing growing concern around rising EV competition and safety issues for Tesla,” said Dan Ives, a Wedbush Securities analyst, in a note to clients early Friday.\nThe safety issues Ives mentions are what investors should be attuned to right now, because it appears the government is finally stepping up and taking note of a problem this column has long pointed out: Musk repeatedly oversells the current and near-term potential for his automotive autonomy advanced technology.\nJust a day before Thursday’s “AI Day” spectacle,two U.S. senators asked the Federal Trade Commission to investigate both Tesla’s and Musk’s “repeated overstatements of their vehicles’ capabilities”in regards to the marketing of Tesla’s “Full Self Driving” product. Tesla charges thousands of dollars at purchase (or as little as $100 a month) for software that is nowhere near full self-driving, a practice that has already led toa recent review by California Department of Motor Vehiclesanda German ruling that Tesla could not market the product as such.\n“Language matters,” said Selika Talbott, a professorial lecturer in the department of public administration and policy at American University in Washington DC. “The use of this terminology is false and misleading and unsafe for the general public. The notions of assisted driving and autonomous vehicles and their differences are not fully understood by the general public.”\n“Tesla has highly assisted technology in their vehicle, but at no point should anyone behind the wheel think that vehicle can drive itself, because it can’t,” Talbott said.\nThe week began with news of a federal investigation into Tesla’s Autopilot system after cars using the feature crashed into stopped emergency vehicles.The National Highway Traffic Safety Administration is looking into a series of crashesby Tesla cars that had the advanced driver-assistance system enabled. NHTSA said that itopened an inquiry into 11 Tesla crashesthat involved emergency vehicles, while still investigating a series of collisions involving cars enabled with Advanced Driver Assistance Systems (ADAS) and tractor-trailers.\nThe latest outcry on Capitol Hill follows a stream of news reports and/or social media posts and YouTube videos of drivers engaging in extremely risky behavior while testing the so-called self-driving features of their Tesla. In May, Steven Michael Hendrickson,a 35-year-old father of two in Fontana, Calif., died when his Tesla hit an overturned semitruck. Earlier he had posted videos of driving without his hands on the wheel of his car on the freeway, but the NHTSA was still investigating the role of Autopilot in the crash.\n“The vehicles that Tesla is producing are driver-assisted systems,” said Bryan Reimer, a research scientist at the MIT Center for Transportation and Logistics. “They are assisting the driver, and the driver needs to maintain vigilance.”\nIt is important to note the difference between Tesla’s dual products with misleading names. “Autopilot” is an ADAS system, a highly advanced version of cruise control meant for highway driving that enables “your car to steer, accelerate and brake automatically within its lane under your active supervision, assisting with the most burdensome parts of driving,” according to Tesla’s website. Tesla also offers the “FSD” package, now available by a subscription of $99 to $199 a month, which it describes as “access to a suite of more advanced driver assistance features, designed to provide more active guidance and assisted driving under your active supervision.”\nIf only Musk described these systems in a similar manner to the official website. In analyst conference calls and in Tesla’s multi-hour long presentations to its fan base, Musk has been proclaiming that with this software, full autonomy is around the corner.\n“We basically have to solve real-world vision AI and we are,” he said in an earnings call in April. “And the key to solving this is also having some massive data set. So just having well over one million cars on the road that are collecting data… But I am highly confident that we will get this done.”\nBut for all of Musk’s bluster and huge fan base, investors are starting to note that the company’s tactics involving full self-driving technology are dangerous, as opposed to the other companies that are testing autonomous vehicles.\nFor example, Alphabet Inc.’sGOOGGOOGLWaymo, the company with the most hours of autonomous vehicle driving, is currently operating a small scale robotaxi service in parts of Arizona around Phoenix that are not densely populated, without human drivers. It is the only one of its kind in the U.S. In California, Waymo has permits from the DMV to conduct AV testing with a human driver behind the wheel.\n“Waymo cannot just start selling their AVs to anyone, and they can’t just drive them on the roadway, our regulatory system does not allow for that,” Talbott of American University said. “You can test them but no publicly available self-driving car is on the market for purchase because it doesn’t exist.”\nWith FSD testing being done in the real world with untrained drivers, Tesla is conducting the equivalent of clinical trials of a new drug without any professional hourly or daily monitoring of the patient.\n“They are calling it beta, it is a beta system, they are exposing people to substantive risk,” Reimer said.\nMusk’s latest bot is yet another distraction, much like the flame thrower in 2018 sold by his Boring Company, his unwanted assistance to try and help the boys stuck in a cave in Thailand, and other projects. Investors should not let these distractions get in the way of the real issues that Musk seems to be refusing to acknowledge as he continues to oversell his company’s technological abilities.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899224317,"gmtCreate":1628202729639,"gmtModify":1633752773370,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/899224317","repostId":"1117772028","repostType":4,"repost":{"id":"1117772028","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628174192,"share":"https://www.laohu8.com/m/news/1117772028?lang=zh_CN&edition=full","pubTime":"2021-08-05 22:36","market":"us","language":"en","title":"Airline shares, Carnival stocks rally in morning trading<blockquote>航空股、嘉年华股早盘上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1117772028","media":"Tiger Newspress","summary":"(Aug&nbsp;5)&nbsp;Airline shares, Carnival stocks&nbsp;rally&nbsp;in&nbsp;morning&nbsp;trading.","content":"<p>(Aug&nbsp;5)&nbsp;Airline shares, Carnival stocks&nbsp;rally&nbsp;in&nbsp;morning&nbsp;trading.</p><p><blockquote>（8月5日）航空股、嘉年华股早盘上涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/42a38b66aa352091811cb924ece1b676\" tg-width=\"374\" tg-height=\"366\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Airline shares, Carnival stocks rally in morning trading<blockquote>航空股、嘉年华股早盘上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAirline shares, Carnival stocks rally in morning trading<blockquote>航空股、嘉年华股早盘上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-05 22:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Airline shares, Carnival stocks&nbsp;rally&nbsp;in&nbsp;morning&nbsp;trading.</p><p><blockquote>（8月5日）航空股、嘉年华股早盘上涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/42a38b66aa352091811cb924ece1b676\" tg-width=\"374\" tg-height=\"366\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117772028","content_text":"(Aug 5) Airline shares, Carnival stocks rally in morning trading.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":877268094,"gmtCreate":1637936893745,"gmtModify":1637936893811,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877268094","repostId":"1116442909","repostType":4,"isVote":1,"tweetType":1,"viewCount":692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879889822,"gmtCreate":1636702174701,"gmtModify":1636702174848,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/879889822","repostId":"2182985220","repostType":4,"repost":{"id":"2182985220","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1636701748,"share":"https://www.laohu8.com/m/news/2182985220?lang=zh_CN&edition=full","pubTime":"2021-11-12 15:22","market":"hk","language":"en","title":"Is AFRM A Buy Now? What Affirm's Fundamentals, IBD Ratings, Stock Chart Say<blockquote>AFRM现在值得买入吗？Affirm的基本面、IBD评级、股票图表说明了什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2182985220","media":"Investors","summary":"In this situation, you want to buy as close as possible to the actual 50-day or 10-week line itself.","content":"<p>When it comes to investing in new fintech companies and the financing concept of BNPL — buy now, pay later — Affirm stock comes immediately to mind. And what a sensational week of action it's having.</p><p><blockquote>当谈到投资新的金融科技公司和BNPL的融资理念——先买后付——Affirm stock立即浮现在脑海中。这是多么激动人心的一周啊。</blockquote></p><p> <b>Affirm</b> likely scared the wits of shareholders on Wednesday.</p><p><blockquote><b>申明</b>周三可能吓坏了股东的智慧。</blockquote></p><p> The stock nose-dived 15% in the heaviest volume in more than three weeks. More than 22.5 million shares exchanged hands that day, 42% above its average turnover over the past 50 sessions. Affirm stock also came close to undercutting a critical technical level on its chart, the 50-day moving average.</p><p><blockquote>该股暴跌15%，创三周多来最大成交量。当天成交量超过2250万股，比过去50个交易日的平均成交量高出42%。Affirm股票也接近跌破其图表上的关键技术水平，即50日移动平均线。</blockquote></p><p> But after reporting third-quarter results late Wednesday, AFRM went into bungee cord-jumping mode. Shares rose as much as 24% intraday on Thursday, then settled at 151.83. Good for a 13.7% gain.</p><p><blockquote>但在周三晚些时候公布第三季度业绩后，AFRM进入了蹦极模式。周四盘中股价一度上涨24%，最终收于151.83点。有利于13.7%的涨幅。</blockquote></p><p> Volume soared again, rising more than double its usual level.</p><p><blockquote>成交量再次飙升，上涨了平时的两倍多。</blockquote></p><p> Even amid this hyper-volatility, the fintech company, started by Max Levchin, entrepreneur and member of the so-called \"<a href=\"https://laohu8.com/S/PYPL\">PayPal</a> mafia\" of Silicon Valley fame, boasts a 209% gain from its initial public offering at $49 a share in January.</p><p><blockquote>即使在这种极度波动的情况下，这家由企业家兼所谓“<a href=\"https://laohu8.com/S/PYPL\">PayPal</a>以硅谷闻名的“黑手党”自1月份以每股49美元的价格首次公开募股以来，股价上涨了209%。</blockquote></p><p> <h2>Is Affirm Stock A Buy Now?</h2> This story addresses aspects of IBD's CAN SLIM investment paradigm, coined by the legendary growth stock trader and founder of Investor's Business Daily, William O'Neil. So, we'll analyze the potential investment from multiple viewpoints: fundamental, technical and the quantity and quality of institutional ownership.</p><p><blockquote><h2>Affirm股票现在值得买入吗？</h2>这个故事讲述了IBD的CAN SLIM投资范式的各个方面，该范式由传奇成长型股票交易员兼《投资者商业日报》创始人威廉·奥尼尔(William O'Neil)创造。因此，我们将从多个角度分析潜在的投资：基本面、技术面以及机构所有权的数量和质量。</blockquote></p><p> Without all three positive elements in place, a growth investor sports a smaller chance of reaping an outstanding market-beating gain over the long run.</p><p><blockquote>如果没有这三个积极因素，从长远来看，成长型投资者获得跑赢市场的出色收益的机会就会较小。</blockquote></p><p> <h2>Affirm Stock Today: The IBD Ratings Picture</h2> IBD Stock Checkup shows Affirm with a Composite Rating of 62 on a scale of 1 to 99.</p><p><blockquote><h2>今天确认股票：IBD评级图片</h2>IBD股票检查显示肯定，在1到99的范围内，综合评级为62。</blockquote></p><p> That compares unfavorably with Affirm's industry peers in consumer credit and banking giants, including <b>American Express</b>, <b>Square</b>, <b>Goldman Sachs</b>,&nbsp;<b>Discover Financial</b> and <b>Mastercard</b>. Affirm's Composite, however, beats <b>PayPal</b>, a struggling member of IBD Long-Term Leaders and former member of IBD Big Cap 20.</p><p><blockquote>与Affirm的消费信贷和银行巨头行业同行相比，这是不利的，包括<b>美国运通</b>,<b>平方</b>,<b>高盛</b>, <b>发现金融</b>和<b>万事达卡</b>.然而，Affirm的综合表现优于<b>PayPal</b>，IBD长期领导者的苦苦挣扎的成员，也是IBD Big Cap 20的前成员。</blockquote></p><p> Ideally, focus on companies with a 90 Composite or higher. However, newer issues often have no earnings history or a very slim record of profitability. For Affirm, the San Francisco-based company lost $1.75 a share in fiscal 2021, ended in June. The Street sees more net losses in FY 2022 (-$1.01) and FY 2023 (-$0.83). Affirm has 269.4 million shares outstanding.</p><p><blockquote>理想情况下，关注综合指数为90或更高的公司。然而，较新的发行通常没有盈利历史或盈利记录非常微弱。对于Affirm来说，这家总部位于旧金山的公司在截至6月的2021财年每股亏损1.75美元。华尔街预计2022财年（-1.01美元）和2023财年（-0.83美元）的净亏损会更多。Affirm拥有2.694亿股已发行股票。</blockquote></p><p> On the positive side, however, Affirm is growing the top line at lightning pace; revenues have grown 86%, 89%, 120%, 98%, 57%, 67%, 71% and 55% vs. year-ago levels in the past eight quarters.</p><p><blockquote>然而，从积极的一面来看，Affirm的营收正在以闪电般的速度增长；过去八个季度的收入与去年同期相比增长了86%、89%、120%、98%、57%、67%、71%和55%。</blockquote></p><p> Mutual fund ownership jumped to 321 funds at the end of Q3 this year vs. 255 in June. Bullish.</p><p><blockquote>今年第三季度末，共同基金拥有量跃升至321只，而6月份为255只。看涨的。</blockquote></p><p> When investing in a growth stock, make sure it has solid company. Does it belong to a leading sector in the stock market itself?</p><p><blockquote>投资成长型股票时，确保它有可靠的公司。属于股市本身的龙头板块吗？</blockquote></p><p> Overall, that's pretty much the case for Affirm. While its credit card payment and processing industry group ranks in the middle at No. 100 among 197 IBD industry groups for six-month price performance, the finance sector holds a respectable 5th rung among 33 sectors in the IBD stock research tables at Investors.com.</p><p><blockquote>总体而言，Affirm的情况大致如此。虽然其信用卡支付和处理行业集团在IBD 197个行业集团中排名第100位，但在Investors.com的IBD股票研究表中，金融行业在33个行业中排名第五。</blockquote></p><p> <hr> <b>Join IBD Live! Trade In Real Time With CAN SLIM Investing Experts</b></p><p><blockquote><hr/><b>加入IBD直播！与CAN SLIM投资专家实时交易</b></blockquote></p><p> <hr> <h2>Affirm Stock: Proper Buy Points</h2> Affirm's stock price corrected in a huge way after its breakout attempt past a 138.08 correct buy point in a narrow IPO base imploded. As you can see on the daily chart, in early February the large cap failed to get much traction after clearing the base's left-side high of 137.98.</p><p><blockquote><hr/><h2>确认股票：适当的买入点</h2>Affirm在狭窄的IPO基础上突破138.08正确买入点的尝试失败后，股价大幅回调。正如您在日线图上看到的，2月初，大盘股在突破底部左侧高点137.98后未能获得太大牵引力。</blockquote></p><p> Then it tanked just days later. This negative price action triggered the golden rule of investing: cut your losses short. By saving precious capital, you insure the portfolio from a devastating loss. And you ensure the opportunity to invest in a better stock or the same stock in stronger market conditions.</p><p><blockquote>几天后它就沉没了。这种负面的价格走势触发了投资的黄金法则：减少损失。通过节省宝贵的资本，您可以确保投资组合免受毁灭性损失。并且您确保有机会在更强劲的市场条件下投资更好的股票或同一只股票。</blockquote></p><p> For Affirm stock, the new opportunity came months later.</p><p><blockquote>对于Affirm stock来说，新的机会在几个月后到来。</blockquote></p><p> After falling as much as 68% from its 146.90 peak, AFRM bottomed out at 46.50 in May, then began to rise slowly. It took months for the stock to begin building the right side of a promising new chart pattern. But it eventually crossed above the 50-day moving average and stayed above it.</p><p><blockquote>AFRM从146.90的峰值下跌68%后，于5月份触底至46.50，然后开始缓慢上涨。该股花了几个月的时间才开始构建有希望的新图表模式的右侧。但最终上穿50日均线上方，并保持在上方。</blockquote></p><p> On Aug. 30, shares gapped up in bullish fashion. A 46% gain in the heaviest volume in the stock's history catapulted Affirm to a five-month high, thanks to a business tie-up with an e-commerce titan. The next several days saw the stock tilt lower in mild fashion. Volume was still heavy, but declined from the mega-active day of Aug. 30.</p><p><blockquote>8月30日，股价以看涨的方式跳空上涨。由于与一家电子商务巨头的业务合作，Affirm股价上涨46%，创下该股历史最大成交量，创下五个月新高。接下来的几天，该股小幅走低。成交量仍然很大，但较8月30日的超级活跃日有所下降。</blockquote></p><p> This constructive price action created a handle on the deep cup.</p><p><blockquote>这种建设性的价格行为在深杯上创造了一个手柄。</blockquote></p><p></p><p> View a handle as a final shakeout of uncommitted, weak shareholders. Those shares move to firmer hands. The handle clears the deck for a breakout — that is, a strong move to new highs once fresh institutional demand crowds the market for Affirm stock.</p><p><blockquote>将手柄视为对未承诺、弱势股东的最终洗牌。这些股份转移到更坚定的手中。该手柄为突破扫清了障碍——也就是说，一旦新的机构需求涌入市场，Affirm股票就会强劲升至新高。</blockquote></p><p> <h2>AFRM Stock: A Follow-On Entry</h2> On Sept. 10, Affirm stock broke out past the handle buy point of 101.10 on second-quarter results. Volume surged again. This move stoked AFRM's first breakout and legitimate buy opportunity.</p><p><blockquote><h2>AFRM股票：后续入场</h2>9月10日，Affirm股价因第二季度业绩突破101.10的买入点。成交量再度大涨。此举引发了AFRM的首次突破和合法买入机会。</blockquote></p><p> <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> separate pullbacks in September and early October created additional handle entries. Why? AFRM was still trading beneath the deep cup pattern's left-side peak of 146.90.</p><p><blockquote><a href=\"https://laohu8.com/S/TWOA.U\">两个</a>9月和10月初的单独回调创造了额外的手柄条目。为什么？AFRM仍在深杯形态左侧峰值146.90下方交易。</blockquote></p><p> Thus, new entry points at 126.56 (10 cents above the Sept. 10 peak) and 133.27 (a dime above the Sept. 24 high) gave traders another chance to buy on strength. Always buy within the 5% buy zone after a breakout.</p><p><blockquote>因此，126.56（比9月10日峰值高出10美分）和133.27（比9月24日高点高出1美分）的新进场点给了交易者另一次强势买入的机会。突破后始终在5%买入区域内买入。</blockquote></p><p> Since then, the Affirm stock price has moved the way you'd expect: up.</p><p><blockquote>从那时起，Affirm的股价就按照您预期的方式上涨。</blockquote></p><p> This new pullback to the 50-day moving average, or to the 10-week line on a weekly chart, offers a follow-on buy point after a successful breakout.</p><p><blockquote>这一新的回调至50日移动平均线或周线图上的10周线，在成功突破后提供了后续买入点。</blockquote></p><p> In this situation, you want to buy as close as possible to the actual 50-day or 10-week itself.</p><p><blockquote>在这种情况下，您希望购买尽可能接近实际的50天或10周本身。</blockquote></p><p> The 10-week moving average has risen to around 140.32 as of Thursday's close. Buying within 5% to 10% of this price level is acceptable — but only if IBD says the market is in a confirmed uptrend. You want the market acting as a tailwind, not a headwind.</p><p><blockquote>截至周四收盘，10周均线已升至140.32附近。在该价格水平的5%至10%范围内买入是可以接受的，但前提是IBD表示市场处于确认的上升趋势。你希望市场成为顺风，而不是逆风。</blockquote></p><p> So at this point, Affirm stock is a buy.</p><p><blockquote>因此，目前，Affirm股票值得买入。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is AFRM A Buy Now? What Affirm's Fundamentals, IBD Ratings, Stock Chart Say<blockquote>AFRM现在值得买入吗？Affirm的基本面、IBD评级、股票图表说明了什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs AFRM A Buy Now? What Affirm's Fundamentals, IBD Ratings, Stock Chart Say<blockquote>AFRM现在值得买入吗？Affirm的基本面、IBD评级、股票图表说明了什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time smaller\">2021-11-12 15:22</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>When it comes to investing in new fintech companies and the financing concept of BNPL — buy now, pay later — Affirm stock comes immediately to mind. And what a sensational week of action it's having.</p><p><blockquote>当谈到投资新的金融科技公司和BNPL的融资理念——先买后付——Affirm stock立即浮现在脑海中。这是多么激动人心的一周啊。</blockquote></p><p> <b>Affirm</b> likely scared the wits of shareholders on Wednesday.</p><p><blockquote><b>申明</b>周三可能吓坏了股东的智慧。</blockquote></p><p> The stock nose-dived 15% in the heaviest volume in more than three weeks. More than 22.5 million shares exchanged hands that day, 42% above its average turnover over the past 50 sessions. Affirm stock also came close to undercutting a critical technical level on its chart, the 50-day moving average.</p><p><blockquote>该股暴跌15%，创三周多来最大成交量。当天成交量超过2250万股，比过去50个交易日的平均成交量高出42%。Affirm股票也接近跌破其图表上的关键技术水平，即50日移动平均线。</blockquote></p><p> But after reporting third-quarter results late Wednesday, AFRM went into bungee cord-jumping mode. Shares rose as much as 24% intraday on Thursday, then settled at 151.83. Good for a 13.7% gain.</p><p><blockquote>但在周三晚些时候公布第三季度业绩后，AFRM进入了蹦极模式。周四盘中股价一度上涨24%，最终收于151.83点。有利于13.7%的涨幅。</blockquote></p><p> Volume soared again, rising more than double its usual level.</p><p><blockquote>成交量再次飙升，上涨了平时的两倍多。</blockquote></p><p> Even amid this hyper-volatility, the fintech company, started by Max Levchin, entrepreneur and member of the so-called \"<a href=\"https://laohu8.com/S/PYPL\">PayPal</a> mafia\" of Silicon Valley fame, boasts a 209% gain from its initial public offering at $49 a share in January.</p><p><blockquote>即使在这种极度波动的情况下，这家由企业家兼所谓“<a href=\"https://laohu8.com/S/PYPL\">PayPal</a>以硅谷闻名的“黑手党”自1月份以每股49美元的价格首次公开募股以来，股价上涨了209%。</blockquote></p><p> <h2>Is Affirm Stock A Buy Now?</h2> This story addresses aspects of IBD's CAN SLIM investment paradigm, coined by the legendary growth stock trader and founder of Investor's Business Daily, William O'Neil. So, we'll analyze the potential investment from multiple viewpoints: fundamental, technical and the quantity and quality of institutional ownership.</p><p><blockquote><h2>Affirm股票现在值得买入吗？</h2>这个故事讲述了IBD的CAN SLIM投资范式的各个方面，该范式由传奇成长型股票交易员兼《投资者商业日报》创始人威廉·奥尼尔(William O'Neil)创造。因此，我们将从多个角度分析潜在的投资：基本面、技术面以及机构所有权的数量和质量。</blockquote></p><p> Without all three positive elements in place, a growth investor sports a smaller chance of reaping an outstanding market-beating gain over the long run.</p><p><blockquote>如果没有这三个积极因素，从长远来看，成长型投资者获得跑赢市场的出色收益的机会就会较小。</blockquote></p><p> <h2>Affirm Stock Today: The IBD Ratings Picture</h2> IBD Stock Checkup shows Affirm with a Composite Rating of 62 on a scale of 1 to 99.</p><p><blockquote><h2>今天确认股票：IBD评级图片</h2>IBD股票检查显示肯定，在1到99的范围内，综合评级为62。</blockquote></p><p> That compares unfavorably with Affirm's industry peers in consumer credit and banking giants, including <b>American Express</b>, <b>Square</b>, <b>Goldman Sachs</b>,&nbsp;<b>Discover Financial</b> and <b>Mastercard</b>. Affirm's Composite, however, beats <b>PayPal</b>, a struggling member of IBD Long-Term Leaders and former member of IBD Big Cap 20.</p><p><blockquote>与Affirm的消费信贷和银行巨头行业同行相比，这是不利的，包括<b>美国运通</b>,<b>平方</b>,<b>高盛</b>, <b>发现金融</b>和<b>万事达卡</b>.然而，Affirm的综合表现优于<b>PayPal</b>，IBD长期领导者的苦苦挣扎的成员，也是IBD Big Cap 20的前成员。</blockquote></p><p> Ideally, focus on companies with a 90 Composite or higher. However, newer issues often have no earnings history or a very slim record of profitability. For Affirm, the San Francisco-based company lost $1.75 a share in fiscal 2021, ended in June. The Street sees more net losses in FY 2022 (-$1.01) and FY 2023 (-$0.83). Affirm has 269.4 million shares outstanding.</p><p><blockquote>理想情况下，关注综合指数为90或更高的公司。然而，较新的发行通常没有盈利历史或盈利记录非常微弱。对于Affirm来说，这家总部位于旧金山的公司在截至6月的2021财年每股亏损1.75美元。华尔街预计2022财年（-1.01美元）和2023财年（-0.83美元）的净亏损会更多。Affirm拥有2.694亿股已发行股票。</blockquote></p><p> On the positive side, however, Affirm is growing the top line at lightning pace; revenues have grown 86%, 89%, 120%, 98%, 57%, 67%, 71% and 55% vs. year-ago levels in the past eight quarters.</p><p><blockquote>然而，从积极的一面来看，Affirm的营收正在以闪电般的速度增长；过去八个季度的收入与去年同期相比增长了86%、89%、120%、98%、57%、67%、71%和55%。</blockquote></p><p> Mutual fund ownership jumped to 321 funds at the end of Q3 this year vs. 255 in June. Bullish.</p><p><blockquote>今年第三季度末，共同基金拥有量跃升至321只，而6月份为255只。看涨的。</blockquote></p><p> When investing in a growth stock, make sure it has solid company. Does it belong to a leading sector in the stock market itself?</p><p><blockquote>投资成长型股票时，确保它有可靠的公司。属于股市本身的龙头板块吗？</blockquote></p><p> Overall, that's pretty much the case for Affirm. While its credit card payment and processing industry group ranks in the middle at No. 100 among 197 IBD industry groups for six-month price performance, the finance sector holds a respectable 5th rung among 33 sectors in the IBD stock research tables at Investors.com.</p><p><blockquote>总体而言，Affirm的情况大致如此。虽然其信用卡支付和处理行业集团在IBD 197个行业集团中排名第100位，但在Investors.com的IBD股票研究表中，金融行业在33个行业中排名第五。</blockquote></p><p> <hr> <b>Join IBD Live! Trade In Real Time With CAN SLIM Investing Experts</b></p><p><blockquote><hr/><b>加入IBD直播！与CAN SLIM投资专家实时交易</b></blockquote></p><p> <hr> <h2>Affirm Stock: Proper Buy Points</h2> Affirm's stock price corrected in a huge way after its breakout attempt past a 138.08 correct buy point in a narrow IPO base imploded. As you can see on the daily chart, in early February the large cap failed to get much traction after clearing the base's left-side high of 137.98.</p><p><blockquote><hr/><h2>确认股票：适当的买入点</h2>Affirm在狭窄的IPO基础上突破138.08正确买入点的尝试失败后，股价大幅回调。正如您在日线图上看到的，2月初，大盘股在突破底部左侧高点137.98后未能获得太大牵引力。</blockquote></p><p> Then it tanked just days later. This negative price action triggered the golden rule of investing: cut your losses short. By saving precious capital, you insure the portfolio from a devastating loss. And you ensure the opportunity to invest in a better stock or the same stock in stronger market conditions.</p><p><blockquote>几天后它就沉没了。这种负面的价格走势触发了投资的黄金法则：减少损失。通过节省宝贵的资本，您可以确保投资组合免受毁灭性损失。并且您确保有机会在更强劲的市场条件下投资更好的股票或同一只股票。</blockquote></p><p> For Affirm stock, the new opportunity came months later.</p><p><blockquote>对于Affirm stock来说，新的机会在几个月后到来。</blockquote></p><p> After falling as much as 68% from its 146.90 peak, AFRM bottomed out at 46.50 in May, then began to rise slowly. It took months for the stock to begin building the right side of a promising new chart pattern. But it eventually crossed above the 50-day moving average and stayed above it.</p><p><blockquote>AFRM从146.90的峰值下跌68%后，于5月份触底至46.50，然后开始缓慢上涨。该股花了几个月的时间才开始构建有希望的新图表模式的右侧。但最终上穿50日均线上方，并保持在上方。</blockquote></p><p> On Aug. 30, shares gapped up in bullish fashion. A 46% gain in the heaviest volume in the stock's history catapulted Affirm to a five-month high, thanks to a business tie-up with an e-commerce titan. The next several days saw the stock tilt lower in mild fashion. Volume was still heavy, but declined from the mega-active day of Aug. 30.</p><p><blockquote>8月30日，股价以看涨的方式跳空上涨。由于与一家电子商务巨头的业务合作，Affirm股价上涨46%，创下该股历史最大成交量，创下五个月新高。接下来的几天，该股小幅走低。成交量仍然很大，但较8月30日的超级活跃日有所下降。</blockquote></p><p> This constructive price action created a handle on the deep cup.</p><p><blockquote>这种建设性的价格行为在深杯上创造了一个手柄。</blockquote></p><p></p><p> View a handle as a final shakeout of uncommitted, weak shareholders. Those shares move to firmer hands. The handle clears the deck for a breakout — that is, a strong move to new highs once fresh institutional demand crowds the market for Affirm stock.</p><p><blockquote>将手柄视为对未承诺、弱势股东的最终洗牌。这些股份转移到更坚定的手中。该手柄为突破扫清了障碍——也就是说，一旦新的机构需求涌入市场，Affirm股票就会强劲升至新高。</blockquote></p><p> <h2>AFRM Stock: A Follow-On Entry</h2> On Sept. 10, Affirm stock broke out past the handle buy point of 101.10 on second-quarter results. Volume surged again. This move stoked AFRM's first breakout and legitimate buy opportunity.</p><p><blockquote><h2>AFRM股票：后续入场</h2>9月10日，Affirm股价因第二季度业绩突破101.10的买入点。成交量再度大涨。此举引发了AFRM的首次突破和合法买入机会。</blockquote></p><p> <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> separate pullbacks in September and early October created additional handle entries. Why? AFRM was still trading beneath the deep cup pattern's left-side peak of 146.90.</p><p><blockquote><a href=\"https://laohu8.com/S/TWOA.U\">两个</a>9月和10月初的单独回调创造了额外的手柄条目。为什么？AFRM仍在深杯形态左侧峰值146.90下方交易。</blockquote></p><p> Thus, new entry points at 126.56 (10 cents above the Sept. 10 peak) and 133.27 (a dime above the Sept. 24 high) gave traders another chance to buy on strength. Always buy within the 5% buy zone after a breakout.</p><p><blockquote>因此，126.56（比9月10日峰值高出10美分）和133.27（比9月24日高点高出1美分）的新进场点给了交易者另一次强势买入的机会。突破后始终在5%买入区域内买入。</blockquote></p><p> Since then, the Affirm stock price has moved the way you'd expect: up.</p><p><blockquote>从那时起，Affirm的股价就按照您预期的方式上涨。</blockquote></p><p> This new pullback to the 50-day moving average, or to the 10-week line on a weekly chart, offers a follow-on buy point after a successful breakout.</p><p><blockquote>这一新的回调至50日移动平均线或周线图上的10周线，在成功突破后提供了后续买入点。</blockquote></p><p> In this situation, you want to buy as close as possible to the actual 50-day or 10-week itself.</p><p><blockquote>在这种情况下，您希望购买尽可能接近实际的50天或10周本身。</blockquote></p><p> The 10-week moving average has risen to around 140.32 as of Thursday's close. Buying within 5% to 10% of this price level is acceptable — but only if IBD says the market is in a confirmed uptrend. You want the market acting as a tailwind, not a headwind.</p><p><blockquote>截至周四收盘，10周均线已升至140.32附近。在该价格水平的5%至10%范围内买入是可以接受的，但前提是IBD表示市场处于确认的上升趋势。你希望市场成为顺风，而不是逆风。</blockquote></p><p> So at this point, Affirm stock is a buy.</p><p><blockquote>因此，目前，Affirm股票值得买入。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AFRM":"Affirm Holdings, Inc.","GTLS":"查特工业"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2182985220","content_text":"When it comes to investing in new fintech companies and the financing concept of BNPL — buy now, pay later — Affirm stock comes immediately to mind. And what a sensational week of action it's having.\nAffirm likely scared the wits of shareholders on Wednesday.\nThe stock nose-dived 15% in the heaviest volume in more than three weeks. More than 22.5 million shares exchanged hands that day, 42% above its average turnover over the past 50 sessions. Affirm stock also came close to undercutting a critical technical level on its chart, the 50-day moving average.\nBut after reporting third-quarter results late Wednesday, AFRM went into bungee cord-jumping mode. Shares rose as much as 24% intraday on Thursday, then settled at 151.83. Good for a 13.7% gain.\nVolume soared again, rising more than double its usual level.\nEven amid this hyper-volatility, the fintech company, started by Max Levchin, entrepreneur and member of the so-called \"PayPal mafia\" of Silicon Valley fame, boasts a 209% gain from its initial public offering at $49 a share in January.\nIs Affirm Stock A Buy Now?\nThis story addresses aspects of IBD's CAN SLIM investment paradigm, coined by the legendary growth stock trader and founder of Investor's Business Daily, William O'Neil. So, we'll analyze the potential investment from multiple viewpoints: fundamental, technical and the quantity and quality of institutional ownership.\nWithout all three positive elements in place, a growth investor sports a smaller chance of reaping an outstanding market-beating gain over the long run.\nAffirm Stock Today: The IBD Ratings Picture\nIBD Stock Checkup shows Affirm with a Composite Rating of 62 on a scale of 1 to 99.\nThat compares unfavorably with Affirm's industry peers in consumer credit and banking giants, including American Express, Square, Goldman Sachs, Discover Financial and Mastercard. Affirm's Composite, however, beats PayPal, a struggling member of IBD Long-Term Leaders and former member of IBD Big Cap 20.\nIdeally, focus on companies with a 90 Composite or higher. However, newer issues often have no earnings history or a very slim record of profitability. For Affirm, the San Francisco-based company lost $1.75 a share in fiscal 2021, ended in June. The Street sees more net losses in FY 2022 (-$1.01) and FY 2023 (-$0.83). Affirm has 269.4 million shares outstanding.\nOn the positive side, however, Affirm is growing the top line at lightning pace; revenues have grown 86%, 89%, 120%, 98%, 57%, 67%, 71% and 55% vs. year-ago levels in the past eight quarters.\nMutual fund ownership jumped to 321 funds at the end of Q3 this year vs. 255 in June. Bullish.\nWhen investing in a growth stock, make sure it has solid company. Does it belong to a leading sector in the stock market itself?\nOverall, that's pretty much the case for Affirm. While its credit card payment and processing industry group ranks in the middle at No. 100 among 197 IBD industry groups for six-month price performance, the finance sector holds a respectable 5th rung among 33 sectors in the IBD stock research tables at Investors.com.\n\nJoin IBD Live! Trade In Real Time With CAN SLIM Investing Experts\n\nAffirm Stock: Proper Buy Points\nAffirm's stock price corrected in a huge way after its breakout attempt past a 138.08 correct buy point in a narrow IPO base imploded. As you can see on the daily chart, in early February the large cap failed to get much traction after clearing the base's left-side high of 137.98.\nThen it tanked just days later. This negative price action triggered the golden rule of investing: cut your losses short. By saving precious capital, you insure the portfolio from a devastating loss. And you ensure the opportunity to invest in a better stock or the same stock in stronger market conditions.\nFor Affirm stock, the new opportunity came months later.\nAfter falling as much as 68% from its 146.90 peak, AFRM bottomed out at 46.50 in May, then began to rise slowly. It took months for the stock to begin building the right side of a promising new chart pattern. But it eventually crossed above the 50-day moving average and stayed above it.\nOn Aug. 30, shares gapped up in bullish fashion. A 46% gain in the heaviest volume in the stock's history catapulted Affirm to a five-month high, thanks to a business tie-up with an e-commerce titan. The next several days saw the stock tilt lower in mild fashion. Volume was still heavy, but declined from the mega-active day of Aug. 30.\nThis constructive price action created a handle on the deep cup.\nView a handle as a final shakeout of uncommitted, weak shareholders. Those shares move to firmer hands. The handle clears the deck for a breakout — that is, a strong move to new highs once fresh institutional demand crowds the market for Affirm stock.\nAFRM Stock: A Follow-On Entry\nOn Sept. 10, Affirm stock broke out past the handle buy point of 101.10 on second-quarter results. Volume surged again. This move stoked AFRM's first breakout and legitimate buy opportunity.\nTwo separate pullbacks in September and early October created additional handle entries. Why? AFRM was still trading beneath the deep cup pattern's left-side peak of 146.90.\nThus, new entry points at 126.56 (10 cents above the Sept. 10 peak) and 133.27 (a dime above the Sept. 24 high) gave traders another chance to buy on strength. Always buy within the 5% buy zone after a breakout.\nSince then, the Affirm stock price has moved the way you'd expect: up.\nThis new pullback to the 50-day moving average, or to the 10-week line on a weekly chart, offers a follow-on buy point after a successful breakout.\nIn this situation, you want to buy as close as possible to the actual 50-day or 10-week itself.\nThe 10-week moving average has risen to around 140.32 as of Thursday's close. Buying within 5% to 10% of this price level is acceptable — but only if IBD says the market is in a confirmed uptrend. You want the market acting as a tailwind, not a headwind.\nSo at this point, Affirm stock is a buy.","news_type":1,"symbols_score_info":{"AFRM":0.9,"GTLS":0.9}},"isVote":1,"tweetType":1,"viewCount":669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849622049,"gmtCreate":1635754040612,"gmtModify":1635754040612,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849622049","repostId":"1165145383","repostType":4,"repost":{"id":"1165145383","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635753604,"share":"https://www.laohu8.com/m/news/1165145383?lang=zh_CN&edition=full","pubTime":"2021-11-01 16:00","market":"us","language":"en","title":"XPeng shares jumped 2.5% in premarket trading<blockquote>小鹏汽车股价在盘前交易中上涨2.5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1165145383","media":"Tiger Newspress","summary":"XPeng shares jumped 2.5% in premarket trading as XPeng maintained strong momentum in October with a ","content":"<p>XPeng shares jumped 2.5% in premarket trading&nbsp;as&nbsp;XPeng maintained strong momentum in October with a total 10,138 Smart EVs delivered, representing a 233% increase year-over-year and the second month surpassing the 10,000-unit benchmark despite the semiconductor shortage.</p><p><blockquote>小鹏汽车股价在盘前交易中上涨2.5%，小鹏汽车10月份保持强劲势头，共交付10,138辆智能电动汽车，同比增长233%，尽管半导体短缺，但仍连续第二个月突破10,000辆基准。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d797f789ca4be213d2e722a2719f9a09\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> XPeng Inc.&nbsp;today announced its vehicle delivery results for October 2021.</p><p><blockquote>小鹏汽车今天公布了2021年10月的车辆交付结果。</blockquote></p><p> <ul>  <li>10,138 vehicles delivered in October 2021, a 233% increase year-over-year</li>  <li>6,044 P7s delivered in October 2021, a 187% increase year-over-year</li>  <li>66,542 total vehicles delivered year-to-date, a 289% increase year-over-year</li>  <li>Cumulative deliveries exceeded 100,000 as at the end of October 2021</li> </ul> XPeng maintained strong momentum in October with a total 10,138 Smart EVs delivered, representing a 233% increase year-over-year and the second month surpassing the 10,000-unit benchmark despite the semiconductor shortage.</p><p><blockquote><ul><li>2021年10月交付10,138辆，同比增长233%</li><li>2021年10月交付6,044辆P7，同比增长187%</li><li>年初至今共交付66,542辆汽车，同比增长289%</li><li>截至2021年10月底累计交付量突破10万辆</li></ul>小鹏汽车10月份保持强劲势头，共交付10,138辆智能电动汽车，同比增长233%，尽管半导体短缺，但仍连续第二个月突破10,000辆基准。</blockquote></p><p> Deliveries in October consisted of 6,044 P7 smart sports sedans, representing a 187% increase year-over-year. The Company delivered 3,657 G3 and G3i smart SUVs, reaching a monthly record since the G3’s launch in December 2018. The P5 smart family sedans, launched in September 2021, demonstrated strong market appeal with 437 units delivered in October and a solid order backlog.</p><p><blockquote>10月份交付量为6,044辆P7智能运动轿车，同比增长187%。该公司交付了3,657辆G3和G3i智能SUV，创下了自2018年12月G3上市以来的月度最高纪录。2021年9月推出的P5 smart家庭轿车在10月份交付了437辆，积压了稳定的订单，展示了强大的市场吸引力。</blockquote></p><p> As of October 31, 2021, year-to-date total vehicle deliveries reached 66,542, representing a 289% increase year-over-year, including 45,271 P7 deliveries.</p><p><blockquote>截至2021年10月31日，年初至今的汽车总交付量达到66,542辆，同比增长289%，其中P7交付量为45,271辆。</blockquote></p><p> The Company’s cumulative deliveries exceeded 100,000 as at the end of October 2021, reflecting its robust business momentum and customer recognition.</p><p><blockquote>截至2021年10月底，公司累计交付量超过10万辆，反映了其强劲的业务势头和客户的认可。</blockquote></p><p> The Company continues to expand its supercharging facilities to address increasing customer demand. XPeng’s branded supercharging network spans urban commuting thoroughfares and highways through 439 stations across 121 Chinese cities, as of September 30, 2021. The Company now offers free supercharging services to customers at 1,648 stations in 221 cities across China.</p><p><blockquote>该公司继续扩大其超级充电设施，以满足不断增长的客户需求。截至2021年9月30日，小鹏汽车的品牌超级充电网络通过遍布中国121个城市的439个充电站，横跨城市通勤大道和高速公路。该公司目前在中国221个城市的1,648个充电站为客户提供免费超级充电服务。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XPeng shares jumped 2.5% in premarket trading<blockquote>小鹏汽车股价在盘前交易中上涨2.5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXPeng shares jumped 2.5% in premarket trading<blockquote>小鹏汽车股价在盘前交易中上涨2.5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-01 16:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>XPeng shares jumped 2.5% in premarket trading&nbsp;as&nbsp;XPeng maintained strong momentum in October with a total 10,138 Smart EVs delivered, representing a 233% increase year-over-year and the second month surpassing the 10,000-unit benchmark despite the semiconductor shortage.</p><p><blockquote>小鹏汽车股价在盘前交易中上涨2.5%，小鹏汽车10月份保持强劲势头，共交付10,138辆智能电动汽车，同比增长233%，尽管半导体短缺，但仍连续第二个月突破10,000辆基准。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d797f789ca4be213d2e722a2719f9a09\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> XPeng Inc.&nbsp;today announced its vehicle delivery results for October 2021.</p><p><blockquote>小鹏汽车今天公布了2021年10月的车辆交付结果。</blockquote></p><p> <ul>  <li>10,138 vehicles delivered in October 2021, a 233% increase year-over-year</li>  <li>6,044 P7s delivered in October 2021, a 187% increase year-over-year</li>  <li>66,542 total vehicles delivered year-to-date, a 289% increase year-over-year</li>  <li>Cumulative deliveries exceeded 100,000 as at the end of October 2021</li> </ul> XPeng maintained strong momentum in October with a total 10,138 Smart EVs delivered, representing a 233% increase year-over-year and the second month surpassing the 10,000-unit benchmark despite the semiconductor shortage.</p><p><blockquote><ul><li>2021年10月交付10,138辆，同比增长233%</li><li>2021年10月交付6,044辆P7，同比增长187%</li><li>年初至今共交付66,542辆汽车，同比增长289%</li><li>截至2021年10月底累计交付量突破10万辆</li></ul>小鹏汽车10月份保持强劲势头，共交付10,138辆智能电动汽车，同比增长233%，尽管半导体短缺，但仍连续第二个月突破10,000辆基准。</blockquote></p><p> Deliveries in October consisted of 6,044 P7 smart sports sedans, representing a 187% increase year-over-year. The Company delivered 3,657 G3 and G3i smart SUVs, reaching a monthly record since the G3’s launch in December 2018. The P5 smart family sedans, launched in September 2021, demonstrated strong market appeal with 437 units delivered in October and a solid order backlog.</p><p><blockquote>10月份交付量为6,044辆P7智能运动轿车，同比增长187%。该公司交付了3,657辆G3和G3i智能SUV，创下了自2018年12月G3上市以来的月度最高纪录。2021年9月推出的P5 smart家庭轿车在10月份交付了437辆，积压了稳定的订单，展示了强大的市场吸引力。</blockquote></p><p> As of October 31, 2021, year-to-date total vehicle deliveries reached 66,542, representing a 289% increase year-over-year, including 45,271 P7 deliveries.</p><p><blockquote>截至2021年10月31日，年初至今的汽车总交付量达到66,542辆，同比增长289%，其中P7交付量为45,271辆。</blockquote></p><p> The Company’s cumulative deliveries exceeded 100,000 as at the end of October 2021, reflecting its robust business momentum and customer recognition.</p><p><blockquote>截至2021年10月底，公司累计交付量超过10万辆，反映了其强劲的业务势头和客户的认可。</blockquote></p><p> The Company continues to expand its supercharging facilities to address increasing customer demand. XPeng’s branded supercharging network spans urban commuting thoroughfares and highways through 439 stations across 121 Chinese cities, as of September 30, 2021. The Company now offers free supercharging services to customers at 1,648 stations in 221 cities across China.</p><p><blockquote>该公司继续扩大其超级充电设施，以满足不断增长的客户需求。截至2021年9月30日，小鹏汽车的品牌超级充电网络通过遍布中国121个城市的439个充电站，横跨城市通勤大道和高速公路。该公司目前在中国221个城市的1,648个充电站为客户提供免费超级充电服务。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165145383","content_text":"XPeng shares jumped 2.5% in premarket trading as XPeng maintained strong momentum in October with a total 10,138 Smart EVs delivered, representing a 233% increase year-over-year and the second month surpassing the 10,000-unit benchmark despite the semiconductor shortage.\n\nXPeng Inc. today announced its vehicle delivery results for October 2021.\n\n10,138 vehicles delivered in October 2021, a 233% increase year-over-year\n6,044 P7s delivered in October 2021, a 187% increase year-over-year\n66,542 total vehicles delivered year-to-date, a 289% increase year-over-year\nCumulative deliveries exceeded 100,000 as at the end of October 2021\n\nXPeng maintained strong momentum in October with a total 10,138 Smart EVs delivered, representing a 233% increase year-over-year and the second month surpassing the 10,000-unit benchmark despite the semiconductor shortage.\nDeliveries in October consisted of 6,044 P7 smart sports sedans, representing a 187% increase year-over-year. The Company delivered 3,657 G3 and G3i smart SUVs, reaching a monthly record since the G3’s launch in December 2018. The P5 smart family sedans, launched in September 2021, demonstrated strong market appeal with 437 units delivered in October and a solid order backlog.\nAs of October 31, 2021, year-to-date total vehicle deliveries reached 66,542, representing a 289% increase year-over-year, including 45,271 P7 deliveries.\nThe Company’s cumulative deliveries exceeded 100,000 as at the end of October 2021, reflecting its robust business momentum and customer recognition.\nThe Company continues to expand its supercharging facilities to address increasing customer demand. XPeng’s branded supercharging network spans urban commuting thoroughfares and highways through 439 stations across 121 Chinese cities, as of September 30, 2021. The Company now offers free supercharging services to customers at 1,648 stations in 221 cities across China.","news_type":1,"symbols_score_info":{"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":756,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":891179886,"gmtCreate":1628360632845,"gmtModify":1633751480248,"author":{"id":"3560475301779740","authorId":"3560475301779740","name":"AlphBeta","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560475301779740","idStr":"3560475301779740"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/891179886","repostId":"1139912651","repostType":4,"isVote":1,"tweetType":1,"viewCount":398,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}